data_1t55_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1t55 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -53.28 -23.0 7.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -1.153 . . . . 0.0 110.212 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.502 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 20.0 tt -133.04 12.03 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.186 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -110.43 -23.7 11.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.2 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.498 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.2 mttm -59.95 -37.64 51.34 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.223 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HD3' ' CB ' ' A' ' 7' ' ' LYS . 47.2 Cg_endo -98.99 -44.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.999 1.526 . . . . 0.0 110.382 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.534 HD12 HG21 ' A' ' 9' ' ' ILE . 15.7 mm -54.28 -42.23 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.189 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -23.71 64.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.913 . . . . 0.0 110.179 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.79 -42.22 22.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.13 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -18.02 62.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.264 -0.897 . . . . 0.0 110.124 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.183 179.991 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -48.94 -22.1 0.79 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.388 -1.066 . . . . 0.0 110.268 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.463 ' HA ' HD11 ' A' ' 9' ' ' ILE . 17.2 tt -103.62 11.31 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 110.203 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -143.27 -45.6 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.224 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.512 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -53.67 -54.86 41.47 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 0.0 110.096 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 46.8 Cg_endo -70.96 -40.48 3.41 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.069 1.562 . . . . 0.0 110.275 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.465 HD13 ' HG2' ' A' ' 8' ' ' PRO . 2.1 mp -60.23 -40.34 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.477 ' C ' ' CD ' ' A' ' 10' ' ' LYS . 1.9 tmtm? -64.42 -40.86 96.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.91 . . . . 0.0 110.223 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -62.29 -57.35 11.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.349 -0.844 . . . . 0.0 110.132 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 mt -115.79 100.73 8.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 110.12 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 -179.904 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 7' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.423 ' C ' HG22 ' A' ' 5' ' ' ILE . 10.1 tptp -54.9 -17.63 3.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -1.134 . . . . 0.0 110.292 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.423 HG22 ' C ' ' A' ' 4' ' ' LYS . 31.0 pt -127.12 14.67 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -143.27 -37.94 0.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.257 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.509 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 3.6 tttt -58.42 -39.72 77.32 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 110.11 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.4 Cg_endo -86.32 -48.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.852 1.448 . . . . 0.0 110.212 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.422 HD11 ' C ' ' A' ' 5' ' ' ILE . 2.2 mp -51.01 -24.49 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.143 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.41 -29.41 41.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.917 . . . . 0.0 110.114 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.95 -36.93 19.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.288 -0.883 . . . . 0.0 110.14 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 8' ' ' PRO . 24.3 mt -69.0 -22.01 64.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.307 -0.871 . . . . 0.0 110.247 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.221 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.07 13.18 6.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 110.068 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.476 HG22 HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -122.03 -21.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 110.101 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -103.87 -7.46 20.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.177 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.486 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -69.24 -41.78 19.14 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.289 -0.882 . . . . 0.0 110.241 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.486 ' HD3' ' CB ' ' A' ' 7' ' ' LYS . 47.5 Cg_endo -95.3 -35.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.008 1.531 . . . . 0.0 110.335 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.452 HG13 HD11 ' A' ' 5' ' ' ILE . 11.0 mm -59.05 -47.43 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.213 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.463 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 8.4 tmtt? -69.7 -30.42 68.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.163 -0.961 . . . . 0.0 110.219 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.38 -46.98 87.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -0.895 . . . . 0.0 110.23 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -167.37 64.29 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.264 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.626 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 O-C-N 121.413 -0.804 . . . . 0.0 110.845 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -61.48 -23.29 65.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -1.144 . . . . 0.0 110.142 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.8 pt -134.96 31.49 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.223 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.511 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -128.05 -40.46 1.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.919 . . . . 0.0 110.101 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.553 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -76.0 -32.56 1.15 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.866 . . . . 0.0 110.058 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 46.6 Cg_endo -97.27 -23.56 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.955 1.503 . . . . 0.0 110.38 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.557 ' CG2' ' N ' ' A' ' 10' ' ' LYS . 3.5 tt -42.34 -44.37 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.895 . . . . 0.0 110.24 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.557 ' N ' ' CG2' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -95.0 -34.34 12.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.308 -0.87 . . . . 0.0 110.398 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.444 ' HD3' ' O ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -70.43 -39.56 74.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.191 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.3 mt -101.64 6.05 41.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.937 . . . . 0.0 110.12 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.427 ' HB3' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 7' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -75.2 -4.06 36.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -1.124 . . . . 0.0 110.151 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.405 ' O ' HG13 ' A' ' 5' ' ' ILE . 2.5 tp -136.26 5.62 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.206 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 46.8 t-105 -126.57 -43.38 1.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.214 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.54 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 7.0 tttt -56.11 -43.98 99.5 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 110.317 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 46.0 Cg_endo -77.53 -38.84 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.792 1.417 . . . . 0.0 110.494 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.529 ' CD1' ' HG2' ' A' ' 8' ' ' PRO . 1.9 mp -68.05 -14.3 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 109.996 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.65 -26.37 29.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 110.186 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.77 -27.91 10.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.198 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 13' ' ' PHE . 38.5 mt -87.09 -10.82 51.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.239 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.433 ' C ' ' O ' ' A' ' 12' ' ' LEU . 3.8 p90 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.311 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -73.4 -9.91 59.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.332 -1.099 . . . . 0.0 110.285 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.525 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 1.1 pt -128.25 -4.47 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 110.088 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -93.96 -19.52 20.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.097 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.523 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 16.7 mtpt -73.36 -39.91 5.21 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.33 -0.856 . . . . 0.0 110.202 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.4 Cg_endo -86.74 -40.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.933 1.491 . . . . 0.0 110.469 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 13.3 mt -51.55 -31.9 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 110.032 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -94.14 -26.35 16.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 110.052 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.19 -6.56 58.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 110.26 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -170.87 40.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.9 . . . . 0.0 110.292 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' A' ' 9' ' ' ILE . 4.7 t80 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.224 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.41 ' O ' ' HD2' ' A' ' 7' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -81.3 1.52 32.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -1.081 . . . . 0.0 110.146 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.529 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 14.1 pt -124.74 -11.71 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 110.167 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -103.27 -32.83 9.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 110.039 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 29.9 mttp -60.91 -54.25 56.16 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 0.0 110.246 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 46.8 Cg_endo -67.44 -31.03 35.27 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.896 1.472 . . . . 0.0 110.308 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.529 ' CD1' ' O ' ' A' ' 5' ' ' ILE . 1.1 mp -59.56 -26.05 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.656 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.43 -21.67 38.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.817 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -49.91 63.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 110.097 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 mt -74.55 -10.49 59.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.177 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 110.185 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -50.12 -20.97 1.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -1.095 . . . . 0.0 110.356 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.524 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 1.9 tt -144.41 13.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 110.2 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.426 ' CZ3' ' CG2' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -105.72 -40.06 5.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 110.112 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 3.5 ttmt -51.71 -54.4 40.3 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.849 . . . . 0.0 110.296 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.0 Cg_endo -67.59 -43.75 5.25 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.923 1.486 . . . . 0.0 110.196 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.524 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 5.7 mm -49.97 -25.87 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.171 -0.956 . . . . 0.0 109.968 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -92.99 -24.2 18.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.888 . . . . 0.0 110.098 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.29 -17.38 64.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.361 -0.837 . . . . 0.0 110.266 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.428 ' CD2' ' O ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -126.96 15.99 7.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.873 . . . . 0.0 110.117 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.5 t80 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 110.241 179.961 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -76.8 -7.84 56.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -1.136 . . . . 0.0 110.1 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.471 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 9.7 tp -142.62 13.83 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.055 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -122.74 -27.07 4.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.06 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.51 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 17.0 mttt -64.52 -42.8 68.25 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.314 -0.867 . . . . 0.0 110.245 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.6 Cg_endo -84.09 -37.61 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.985 1.518 . . . . 0.0 110.441 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.516 ' N ' ' CD1' ' A' ' 9' ' ' ILE . 1.5 mp -50.43 -46.39 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 0.0 109.904 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.444 ' C ' ' CD ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -66.15 -17.93 65.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.998 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -82.36 -62.77 1.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 110.121 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.5 mt -53.52 -22.04 7.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.184 -0.948 . . . . 0.0 110.037 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.5 t80 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 110.186 179.981 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 6' ' ' TRP . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -46.42 -23.96 0.44 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -1.059 . . . . 0.0 110.265 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.464 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 5.1 tp -103.81 -1.93 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.216 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.425 ' HB2' ' HA3' ' A' ' 3' ' ' GLY . 6.5 m95 -97.46 -33.1 11.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.174 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.545 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -55.59 -36.14 42.33 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 110.036 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 48.2 Cg_endo -92.28 -37.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.985 1.519 . . . . 0.0 110.14 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.464 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 8.1 mt -68.79 -26.11 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.989 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.481 ' O ' ' CD ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -73.32 -29.25 62.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.879 . . . . 0.0 110.102 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -91.84 -39.54 11.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.322 -0.861 . . . . 0.0 110.09 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.34 -25.23 48.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 0.0 110.201 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.258 -179.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.525 ' O ' ' CD ' ' A' ' 8' ' ' PRO . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.491 ' C ' ' CG1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -79.96 47.69 0.9 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -1.173 . . . . 0.0 109.851 179.419 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.491 ' CG1' ' C ' ' A' ' 4' ' ' LYS . 12.3 mt -152.65 -36.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.313 -0.867 . . . . 0.0 110.292 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.452 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 6.0 t-105 -145.1 -36.57 0.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.063 -1.023 . . . . 0.0 110.857 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.549 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -42.59 -27.43 0.27 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.92 . . . . 0.0 110.423 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' A' ' 7' ' ' LYS . 48.7 Cg_endo -115.64 -56.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.771 1.406 . . . . 0.0 110.434 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.459 HD12 ' O ' ' A' ' 5' ' ' ILE . 6.6 mt -44.33 -26.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.339 -0.85 . . . . 0.0 110.294 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.488 ' CD ' ' C ' ' A' ' 10' ' ' LYS . 2.9 tmtt? -61.39 -38.36 86.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.892 . . . . 0.0 110.293 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -76.41 -45.76 30.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 110.374 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.1 mt -77.87 -21.84 50.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 110.375 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.45 ' CB ' ' O ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.193 -0.942 . . . . 0.0 110.255 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -83.4 10.12 9.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -1.152 . . . . 0.0 110.176 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.521 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 12.4 mt -123.96 -16.99 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 110.259 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -101.36 -24.28 14.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.15 -0.969 . . . . 0.0 109.896 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -78.91 -31.99 0.76 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.848 . . . . 0.0 110.298 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 47.4 Cg_endo -91.1 -34.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.795 1.418 . . . . 0.0 110.407 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.521 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 5.5 mt -57.23 -57.6 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 109.703 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -56.6 -26.47 55.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.942 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -48.17 55.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 110.147 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.7 mt -91.14 11.63 22.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.4 t80 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.238 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.8 -12.56 17.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -1.105 . . . . 0.0 110.082 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.512 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 13.1 tt -143.96 40.09 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.001 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 26.6 t-105 -148.12 -37.83 0.19 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.875 . . . . 0.0 110.205 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -63.0 -48.82 83.95 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.345 -0.847 . . . . 0.0 110.253 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.4 Cg_endo -76.14 -36.62 1.82 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.995 1.524 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.512 ' CD1' ' O ' ' A' ' 5' ' ' ILE . 27.5 mt -65.93 -19.58 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.9 . . . . 0.0 110.062 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -85.51 -30.74 23.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 110.046 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -59.37 2.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.69 -60.7 3.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 0.0 110.227 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 6.1 m-30 . . . . . 0 C--N 1.301 -1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 110.284 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.455 ' HA3' ' HB2' ' A' ' 6' ' ' TRP . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 4' ' ' LYS . 11.2 ttmt -60.33 -13.73 14.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.331 -1.099 . . . . 0.0 110.118 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.523 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 10.8 mt -135.16 2.47 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.192 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.455 ' HB2' ' HA3' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -90.43 -29.56 17.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 110.184 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.54 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.0 mtmm -67.78 -37.18 11.25 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 110.356 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 48.5 Cg_endo -84.3 -44.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.654 1.344 . . . . 0.0 110.193 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.523 ' CD1' ' O ' ' A' ' 5' ' ' ILE . 24.7 mt -51.09 -21.82 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.148 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 5.1 tmtt? -77.47 -34.16 54.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 110.232 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -85.17 -53.38 5.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.879 . . . . 0.0 110.22 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.96 -38.91 58.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.229 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 13.7 m-85 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.375 -0.828 . . . . 0.0 110.182 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.01 -17.22 38.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -1.099 . . . . 0.0 110.151 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.527 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 21.5 mm -125.73 -7.17 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 109.99 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.95 -27.83 13.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.01 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.567 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 5.1 tttt -74.77 -34.48 1.79 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 110.356 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 48.5 Cg_endo -87.04 -36.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.726 1.382 . . . . 0.0 110.346 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 6.1 mt -57.67 -37.08 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 109.876 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -20.86 62.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.98 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -68.94 -54.82 13.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 110.195 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.4 mt -89.27 28.6 1.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 110.214 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.902 . . . . 0.0 110.179 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' A' ' 6' ' ' TRP . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.45 -24.37 0.5 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -1.207 . . . . 0.0 109.924 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.425 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 24.1 mt -124.31 3.91 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 110.218 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.501 ' CE2' ' HB3' ' A' ' 10' ' ' LYS . 20.4 t-105 -87.54 -25.45 23.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 110.265 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.538 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -52.07 -33.03 9.97 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 110.285 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 47.7 Cg_endo -99.24 -55.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.041 1.548 . . . . 0.0 110.417 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.2 mm -48.55 -56.23 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.284 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.502 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -67.47 -34.1 76.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.042 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.502 ' N ' ' HG3' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -41.63 -59.03 1.75 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.577 -0.702 . . . . 0.0 110.342 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 mt -76.13 -13.83 60.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.275 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.216 -0.928 . . . . 0.0 110.206 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.423 ' C ' HG13 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -45.51 -34.49 3.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.461 -1.023 . . . . 0.0 110.558 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.462 ' O ' HG22 ' A' ' 5' ' ' ILE . 4.4 mt -128.49 26.21 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 110.36 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.556 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -145.75 -35.99 0.29 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 0.0 110.63 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.506 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -57.62 -38.64 69.56 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 110.093 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 7' ' ' LYS . 46.7 Cg_endo -89.78 -49.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.867 1.456 . . . . 0.0 110.058 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 5' ' ' ILE . 1.3 mp -52.43 -20.32 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.837 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.403 ' CD ' ' C ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -66.71 -30.87 71.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 109.969 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -82.21 -31.87 30.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.076 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.16 -25.64 67.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.15 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 110.206 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -73.46 -0.62 15.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.347 -1.09 . . . . 0.0 110.388 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.521 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 60.1 mt -145.81 20.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 110.012 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -129.08 -26.77 2.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -0.867 . . . . 0.0 110.443 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 9.6 tttp -80.72 -28.15 0.48 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 110.629 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 47.7 Cg_endo -101.12 -27.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.756 1.398 . . . . 0.0 110.672 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.521 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 3.5 mm -53.09 -68.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.128 -0.983 . . . . 0.0 110.082 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.3 -23.63 67.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 110.407 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 1.8 tttt -71.14 -57.2 4.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.44 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.47 -24.3 59.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.167 -0.958 . . . . 0.0 110.459 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.141 -0.974 . . . . 0.0 110.32 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -76.67 -11.08 59.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.366 -1.079 . . . . 0.0 110.41 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.426 ' C ' HD13 ' A' ' 9' ' ' ILE . 9.8 tt -142.84 24.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.243 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 46.4 t-105 -137.98 -36.78 0.6 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.89 . . . . 0.0 110.167 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.511 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -48.96 -45.64 74.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 110.092 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' A' ' 7' ' ' LYS . 46.6 Cg_endo -91.64 -46.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.073 1.565 . . . . 0.0 110.406 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.432 HD11 ' HG2' ' A' ' 8' ' ' PRO . 2.1 mp -50.83 -43.37 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 109.94 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.496 ' C ' ' CD ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -60.1 -18.84 50.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.916 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -26.0 25.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.865 . . . . 0.0 110.161 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.451 HD11 ' O ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -76.2 -22.28 55.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.25 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.161 179.959 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 1' ' ' ILE . 1.5 pt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.22 0.533 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 42.8 mt -112.68 -89.51 0.52 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 110.206 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.43 27.36 61.63 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -53.28 -23.0 7.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -1.153 . . . . 0.0 110.212 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.502 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 20.0 tt -133.04 12.03 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.186 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -110.43 -23.7 11.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.2 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.498 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.2 mttm -59.95 -37.64 51.34 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.223 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HD3' ' CB ' ' A' ' 7' ' ' LYS . 47.2 Cg_endo -98.99 -44.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.999 1.526 . . . . 0.0 110.382 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.534 HD12 HG21 ' A' ' 9' ' ' ILE . 15.7 mm -54.28 -42.23 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.189 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -23.71 64.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.913 . . . . 0.0 110.179 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.79 -42.22 22.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.13 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -18.02 62.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.264 -0.897 . . . . 0.0 110.124 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -110.83 173.47 6.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.183 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.326 0 O-C-N 119.869 -1.77 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 19.8 tt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.22 0.533 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp -65.47 -172.72 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.268 -0.895 . . . . 0.0 110.156 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.66 45.68 1.14 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -48.94 -22.1 0.79 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.388 -1.066 . . . . 0.0 110.268 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.463 ' HA ' HD11 ' A' ' 9' ' ' ILE . 17.2 tt -103.62 11.31 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 110.203 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -143.27 -45.6 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.224 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.512 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -53.67 -54.86 41.47 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 0.0 110.096 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 46.8 Cg_endo -70.96 -40.48 3.41 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.069 1.562 . . . . 0.0 110.275 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.465 HD13 ' HG2' ' A' ' 8' ' ' PRO . 2.1 mp -60.23 -40.34 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.477 ' C ' ' CD ' ' A' ' 10' ' ' LYS . 1.9 tmtm? -64.42 -40.86 96.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.91 . . . . 0.0 110.223 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -62.29 -57.35 11.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.349 -0.844 . . . . 0.0 110.132 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 mt -115.79 100.73 8.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 110.12 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -61.65 129.46 41.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.37 0 O-C-N 119.909 -1.744 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 2' ' ' LEU . 2.7 tt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.202 0.525 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 1' ' ' ILE . 63.9 mt 58.5 148.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.366 -0.834 . . . . 0.0 110.392 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 7' ' ' LYS . . . 43.65 30.18 1.44 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.423 ' C ' HG22 ' A' ' 5' ' ' ILE . 10.1 tptp -54.9 -17.63 3.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -1.134 . . . . 0.0 110.292 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.423 HG22 ' C ' ' A' ' 4' ' ' LYS . 31.0 pt -127.12 14.67 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -143.27 -37.94 0.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.257 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.509 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 3.6 tttt -58.42 -39.72 77.32 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 110.11 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.4 Cg_endo -86.32 -48.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.852 1.448 . . . . 0.0 110.212 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.422 HD11 ' C ' ' A' ' 5' ' ' ILE . 2.2 mp -51.01 -24.49 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.143 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.41 -29.41 41.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.917 . . . . 0.0 110.114 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.95 -36.93 19.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.288 -0.883 . . . . 0.0 110.14 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 8' ' ' PRO . 24.3 mt -69.0 -22.01 64.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.307 -0.871 . . . . 0.0 110.247 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.25 -148.04 0.19 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.221 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.338 0 O-C-N 119.812 -1.805 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.453 ' O ' ' NZ ' ' A' ' 4' ' ' LYS . 2.2 mp . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.266 0.555 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.77 132.02 36.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.92 . . . . 0.0 110.278 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.36 86.02 0.08 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 1' ' ' ILE . 0.0 OUTLIER -85.07 13.18 6.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 110.068 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.476 HG22 HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -122.03 -21.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 110.101 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 10.7 t-105 -103.87 -7.46 20.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.177 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.486 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -69.24 -41.78 19.14 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.289 -0.882 . . . . 0.0 110.241 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.486 ' HD3' ' CB ' ' A' ' 7' ' ' LYS . 47.5 Cg_endo -95.3 -35.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.008 1.531 . . . . 0.0 110.335 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.452 HG13 HD11 ' A' ' 5' ' ' ILE . 11.0 mm -59.05 -47.43 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.213 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.463 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 8.4 tmtt? -69.7 -30.42 68.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.163 -0.961 . . . . 0.0 110.219 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.38 -46.98 87.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -0.895 . . . . 0.0 110.23 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 14' ' ' NH2 . 0.8 OUTLIER -167.37 64.29 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.264 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.626 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -53.22 82.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.413 -0.804 . . . . 0.0 110.845 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . 0.523 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.327 0 O-C-N 119.748 -1.845 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.406 ' O ' HG13 ' A' ' 1' ' ' ILE . 11.4 pt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.201 0.524 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.07 -144.83 0.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 110.226 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.71 89.38 0.09 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -61.48 -23.29 65.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -1.144 . . . . 0.0 110.142 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.8 pt -134.96 31.49 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.223 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.511 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -128.05 -40.46 1.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.919 . . . . 0.0 110.101 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.553 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -76.0 -32.56 1.15 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.866 . . . . 0.0 110.058 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 46.6 Cg_endo -97.27 -23.56 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.955 1.503 . . . . 0.0 110.38 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.557 ' CG2' ' N ' ' A' ' 10' ' ' LYS . 3.5 tt -42.34 -44.37 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.895 . . . . 0.0 110.24 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.557 ' N ' ' CG2' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -95.0 -34.34 12.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.308 -0.87 . . . . 0.0 110.398 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.444 ' HD3' ' O ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -70.43 -39.56 74.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.191 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.3 mt -101.64 6.05 41.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.937 . . . . 0.0 110.12 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.427 ' HB3' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -156.67 101.94 2.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.363 0 O-C-N 119.909 -1.745 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.9 pt . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.237 0.541 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.6 mt -58.49 154.99 12.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.233 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 7' ' ' LYS . . . 51.92 89.49 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -75.2 -4.06 36.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -1.124 . . . . 0.0 110.151 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.405 ' O ' HG13 ' A' ' 5' ' ' ILE . 2.5 tp -136.26 5.62 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.206 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 46.8 t-105 -126.57 -43.38 1.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.214 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.54 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 7.0 tttt -56.11 -43.98 99.5 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 110.317 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 46.0 Cg_endo -77.53 -38.84 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.792 1.417 . . . . 0.0 110.494 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.529 ' CD1' ' HG2' ' A' ' 8' ' ' PRO . 1.9 mp -68.05 -14.3 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 109.996 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.65 -26.37 29.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 110.186 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.77 -27.91 10.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.198 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 13' ' ' PHE . 38.5 mt -87.09 -10.82 51.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.239 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.433 ' C ' ' O ' ' A' ' 12' ' ' LEU . 3.8 p90 -42.13 152.85 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.311 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.343 0 O-C-N 119.867 -1.771 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.848 ' CB ' ' N ' ' A' ' 1' ' ' ILE . . . . . . . . 0 C--O 1.216 -0.693 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.13 136.65 49.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 110.207 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.95 80.54 1.1 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -73.4 -9.91 59.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.332 -1.099 . . . . 0.0 110.285 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.525 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 1.1 pt -128.25 -4.47 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 110.088 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -93.96 -19.52 20.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.097 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.523 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 16.7 mtpt -73.36 -39.91 5.21 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.33 -0.856 . . . . 0.0 110.202 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.4 Cg_endo -86.74 -40.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.933 1.491 . . . . 0.0 110.469 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 13.3 mt -51.55 -31.9 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 110.032 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -94.14 -26.35 16.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 110.052 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.19 -6.56 58.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 110.26 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -170.87 40.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.9 . . . . 0.0 110.292 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' A' ' 9' ' ' ILE . 4.7 t80 -178.45 38.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.224 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.335 0 O-C-N 119.817 -1.802 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.422 ' O ' ' C ' ' A' ' 2' ' ' LEU . 1.5 tp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.182 0.515 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 1' ' ' ILE . 0.2 OUTLIER -42.68 -89.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.23 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.41 ' O ' ' HD2' ' A' ' 7' ' ' LYS . . . 166.73 74.88 0.03 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -81.3 1.52 32.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -1.081 . . . . 0.0 110.146 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.529 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 14.1 pt -124.74 -11.71 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 110.167 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -103.27 -32.83 9.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 110.039 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 29.9 mttp -60.91 -54.25 56.16 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 0.0 110.246 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 46.8 Cg_endo -67.44 -31.03 35.27 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.896 1.472 . . . . 0.0 110.308 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.529 ' CD1' ' O ' ' A' ' 5' ' ' ILE . 1.1 mp -59.56 -26.05 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.656 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.43 -21.67 38.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.817 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -49.91 63.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 110.097 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 mt -74.55 -10.49 59.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.177 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -118.28 29.77 7.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 110.185 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.343 0 O-C-N 119.845 -1.785 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.515 HG21 ' N ' ' A' ' 2' ' ' LEU . 1.5 tt . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.205 0.526 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.515 ' N ' HG21 ' A' ' 1' ' ' ILE . 2.5 mt 56.58 164.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 110.124 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.19 37.07 0.03 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -50.12 -20.97 1.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -1.095 . . . . 0.0 110.356 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.524 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 1.9 tt -144.41 13.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 110.2 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.426 ' CZ3' ' CG2' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -105.72 -40.06 5.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 110.112 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 3.5 ttmt -51.71 -54.4 40.3 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.849 . . . . 0.0 110.296 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.0 Cg_endo -67.59 -43.75 5.25 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.923 1.486 . . . . 0.0 110.196 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.524 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 5.7 mm -49.97 -25.87 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.171 -0.956 . . . . 0.0 109.968 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -92.99 -24.2 18.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.888 . . . . 0.0 110.098 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.29 -17.38 64.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.361 -0.837 . . . . 0.0 110.266 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.428 ' CD2' ' O ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -126.96 15.99 7.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.873 . . . . 0.0 110.117 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -140.39 -48.86 0.44 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 110.241 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.331 0 O-C-N 119.865 -1.772 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.416 ' O ' ' HG ' ' A' ' 2' ' ' LEU . 4.8 mp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.216 0.531 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 1' ' ' ILE . 35.2 mt -144.97 -37.27 0.29 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.331 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.75 90.69 0.08 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -76.8 -7.84 56.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -1.136 . . . . 0.0 110.1 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.471 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 9.7 tp -142.62 13.83 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.055 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -122.74 -27.07 4.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.06 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.51 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 17.0 mttt -64.52 -42.8 68.25 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.314 -0.867 . . . . 0.0 110.245 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.6 Cg_endo -84.09 -37.61 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.985 1.518 . . . . 0.0 110.441 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.516 ' N ' ' CD1' ' A' ' 9' ' ' ILE . 1.5 mp -50.43 -46.39 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 0.0 109.904 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.444 ' C ' ' CD ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -66.15 -17.93 65.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.998 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -82.36 -62.77 1.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 110.121 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.5 mt -53.52 -22.04 7.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.184 -0.948 . . . . 0.0 110.037 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -135.88 56.48 1.82 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 110.186 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.323 0 O-C-N 119.872 -1.767 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 2' ' ' LEU . 3.4 mt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.293 0.568 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 1' ' ' ILE . 6.1 mt 60.54 -84.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.946 . . . . 0.0 110.281 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 1' ' ' ILE . . . -106.44 66.29 0.26 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -46.42 -23.96 0.44 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -1.059 . . . . 0.0 110.265 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.464 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 5.1 tp -103.81 -1.93 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.216 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.425 ' HB2' ' HA3' ' A' ' 3' ' ' GLY . 6.5 m95 -97.46 -33.1 11.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.174 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.545 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -55.59 -36.14 42.33 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 110.036 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 48.2 Cg_endo -92.28 -37.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.985 1.519 . . . . 0.0 110.14 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.464 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 8.1 mt -68.79 -26.11 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.989 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.481 ' O ' ' CD ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -73.32 -29.25 62.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.879 . . . . 0.0 110.102 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -91.84 -39.54 11.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.322 -0.861 . . . . 0.0 110.09 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 14' ' ' NH2 . 0.1 OUTLIER -56.34 -25.23 48.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 0.0 110.201 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -55.8 87.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.258 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . 0.439 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.341 0 O-C-N 119.829 -1.794 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.449 ' CD1' ' N ' ' A' ' 1' ' ' ILE . 2.3 mp . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.199 0.523 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 1' ' ' ILE . 3.3 mp -42.4 -90.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 110.164 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.525 ' O ' ' CD ' ' A' ' 8' ' ' PRO . . . -162.52 91.19 0.11 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.491 ' C ' ' CG1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -79.96 47.69 0.9 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -1.173 . . . . 0.0 109.851 179.419 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.491 ' CG1' ' C ' ' A' ' 4' ' ' LYS . 12.3 mt -152.65 -36.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.313 -0.867 . . . . 0.0 110.292 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.452 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 6.0 t-105 -145.1 -36.57 0.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.063 -1.023 . . . . 0.0 110.857 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.549 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -42.59 -27.43 0.27 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.92 . . . . 0.0 110.423 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' A' ' 7' ' ' LYS . 48.7 Cg_endo -115.64 -56.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.771 1.406 . . . . 0.0 110.434 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.459 HD12 ' O ' ' A' ' 5' ' ' ILE . 6.6 mt -44.33 -26.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.339 -0.85 . . . . 0.0 110.294 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.488 ' CD ' ' C ' ' A' ' 10' ' ' LYS . 2.9 tmtt? -61.39 -38.36 86.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.892 . . . . 0.0 110.293 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -76.41 -45.76 30.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 110.374 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.1 mt -77.87 -21.84 50.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 110.375 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.45 ' CB ' ' O ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -112.36 63.91 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.193 -0.942 . . . . 0.0 110.255 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.355 0 O-C-N 119.845 -1.784 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.456 ' O ' ' N ' ' A' ' 3' ' ' GLY . 3.7 tt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.195 0.522 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 1' ' ' ILE . 0.3 OUTLIER 58.8 -85.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.197 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 1' ' ' ILE . . . 160.5 104.78 0.2 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -83.4 10.12 9.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -1.152 . . . . 0.0 110.176 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.521 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 12.4 mt -123.96 -16.99 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 110.259 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -101.36 -24.28 14.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.15 -0.969 . . . . 0.0 109.896 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -78.91 -31.99 0.76 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.848 . . . . 0.0 110.298 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 47.4 Cg_endo -91.1 -34.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.795 1.418 . . . . 0.0 110.407 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.521 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 5.5 mt -57.23 -57.6 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 109.703 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -56.6 -26.47 55.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.942 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -48.17 55.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 110.147 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.7 mt -91.14 11.63 22.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.4 t80 -81.58 -40.85 22.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.238 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.352 0 O-C-N 119.826 -1.797 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 3' ' ' GLY . 2.4 mp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.249 0.547 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 mt 50.42 -89.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.237 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 1' ' ' ILE . . . -122.13 71.8 0.39 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.8 -12.56 17.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -1.105 . . . . 0.0 110.082 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.512 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 13.1 tt -143.96 40.09 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.001 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 26.6 t-105 -148.12 -37.83 0.19 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.875 . . . . 0.0 110.205 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -63.0 -48.82 83.95 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.345 -0.847 . . . . 0.0 110.253 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.4 Cg_endo -76.14 -36.62 1.82 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.995 1.524 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.512 ' CD1' ' O ' ' A' ' 5' ' ' ILE . 27.5 mt -65.93 -19.58 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.9 . . . . 0.0 110.062 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -85.51 -30.74 23.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 110.046 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -59.37 2.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.69 -60.7 3.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 0.0 110.227 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 6.1 m-30 -79.84 -150.7 0.06 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 110.284 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.345 0 O-C-N 119.825 -1.797 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.409 ' C ' ' HG ' ' A' ' 2' ' ' LEU . 52.2 mt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.29 0.567 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.409 ' HG ' ' C ' ' A' ' 1' ' ' ILE . 3.6 mt -127.82 126.53 41.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.455 ' HA3' ' HB2' ' A' ' 6' ' ' TRP . . . 84.27 89.6 0.8 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 4' ' ' LYS . 11.2 ttmt -60.33 -13.73 14.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.331 -1.099 . . . . 0.0 110.118 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.523 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 10.8 mt -135.16 2.47 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.192 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.455 ' HB2' ' HA3' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -90.43 -29.56 17.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 110.184 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.54 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.0 mtmm -67.78 -37.18 11.25 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 110.356 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 48.5 Cg_endo -84.3 -44.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.654 1.344 . . . . 0.0 110.193 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.523 ' CD1' ' O ' ' A' ' 5' ' ' ILE . 24.7 mt -51.09 -21.82 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.148 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 5.1 tmtt? -77.47 -34.16 54.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 110.232 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -85.17 -53.38 5.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.879 . . . . 0.0 110.22 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.96 -38.91 58.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.229 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 13.7 m-85 -106.62 168.72 8.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.375 -0.828 . . . . 0.0 110.182 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.32 0 O-C-N 119.867 -1.77 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 42.9 mt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.251 0.548 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 mt 51.9 -164.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.223 -0.923 . . . . 0.0 110.258 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 112.1 82.71 1.24 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.01 -17.22 38.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -1.099 . . . . 0.0 110.151 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.527 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 21.5 mm -125.73 -7.17 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 109.99 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.95 -27.83 13.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.01 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.567 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 5.1 tttt -74.77 -34.48 1.79 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 110.356 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 48.5 Cg_endo -87.04 -36.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.726 1.382 . . . . 0.0 110.346 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 6.1 mt -57.67 -37.08 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 109.876 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -20.86 62.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.98 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -68.94 -54.82 13.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 110.195 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.4 mt -89.27 28.6 1.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 110.214 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -106.26 -153.68 0.5 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.902 . . . . 0.0 110.179 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.358 0 O-C-N 119.89 -1.756 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 2' ' ' LEU . 20.1 pt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.233 0.54 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 1' ' ' ILE . 1.5 mt -55.83 -163.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.185 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' A' ' 6' ' ' TRP . . . -78.39 0.06 76.59 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.45 -24.37 0.5 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -1.207 . . . . 0.0 109.924 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.425 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 24.1 mt -124.31 3.91 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 110.218 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.501 ' CE2' ' HB3' ' A' ' 10' ' ' LYS . 20.4 t-105 -87.54 -25.45 23.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 110.265 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.538 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -52.07 -33.03 9.97 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 110.285 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 47.7 Cg_endo -99.24 -55.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.041 1.548 . . . . 0.0 110.417 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.2 mm -48.55 -56.23 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.284 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.502 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -67.47 -34.1 76.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.042 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.502 ' N ' ' HG3' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -41.63 -59.03 1.75 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.577 -0.702 . . . . 0.0 110.342 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 mt -76.13 -13.83 60.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.275 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.27 -83.29 0.61 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.216 -0.928 . . . . 0.0 110.206 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . 0.418 ' N ' ' O ' ' A' ' 10' ' ' LYS . . . . . . . . 0 C--N 1.306 -1.326 0 O-C-N 119.876 -1.765 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 13.1 mm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.257 0.551 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.87 160.75 14.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.197 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.79 70.09 0.24 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.423 ' C ' HG13 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -45.51 -34.49 3.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.461 -1.023 . . . . 0.0 110.558 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.462 ' O ' HG22 ' A' ' 5' ' ' ILE . 4.4 mt -128.49 26.21 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 110.36 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.556 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -145.75 -35.99 0.29 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 0.0 110.63 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.506 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -57.62 -38.64 69.56 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 110.093 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 7' ' ' LYS . 46.7 Cg_endo -89.78 -49.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.867 1.456 . . . . 0.0 110.058 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 5' ' ' ILE . 1.3 mp -52.43 -20.32 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.837 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.403 ' CD ' ' C ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -66.71 -30.87 71.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 109.969 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -82.21 -31.87 30.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.076 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.16 -25.64 67.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.15 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.13 161.79 10.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 110.206 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.367 0 O-C-N 119.855 -1.778 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.489 ' CD1' ' C ' ' A' ' 1' ' ' ILE . 2.6 pp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.221 0.534 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 46.4 mt -108.82 -169.86 1.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 110.134 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 49.44 77.89 0.11 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -73.46 -0.62 15.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.347 -1.09 . . . . 0.0 110.388 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.521 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 60.1 mt -145.81 20.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 110.012 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -129.08 -26.77 2.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -0.867 . . . . 0.0 110.443 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 9.6 tttp -80.72 -28.15 0.48 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 110.629 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 47.7 Cg_endo -101.12 -27.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.756 1.398 . . . . 0.0 110.672 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.521 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 3.5 mm -53.09 -68.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.128 -0.983 . . . . 0.0 110.082 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.3 -23.63 67.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 110.407 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 1.8 tttt -71.14 -57.2 4.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.44 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.47 -24.3 59.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.167 -0.958 . . . . 0.0 110.459 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.0 106.88 19.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.141 -0.974 . . . . 0.0 110.32 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 119.94 -1.725 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 6.4 mt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.206 0.527 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.99 -160.63 0.42 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 110.276 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 156.72 77.02 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -76.67 -11.08 59.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.366 -1.079 . . . . 0.0 110.41 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.426 ' C ' HD13 ' A' ' 9' ' ' ILE . 9.8 tt -142.84 24.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.243 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 46.4 t-105 -137.98 -36.78 0.6 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.89 . . . . 0.0 110.167 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.511 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -48.96 -45.64 74.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 110.092 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' A' ' 7' ' ' LYS . 46.6 Cg_endo -91.64 -46.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.073 1.565 . . . . 0.0 110.406 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.432 HD11 ' HG2' ' A' ' 8' ' ' PRO . 2.1 mp -50.83 -43.37 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 109.94 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.496 ' C ' ' CD ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -60.1 -18.84 50.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.916 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -26.0 25.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.865 . . . . 0.0 110.161 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.451 HD11 ' O ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -76.2 -22.28 55.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.25 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -58.47 -177.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.161 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.367 0 O-C-N 119.877 -1.765 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -53.28 -23.0 7.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -1.153 . . . . 0.0 110.212 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.502 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 20.0 tt -133.04 12.03 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.186 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.406 ' O ' ' HB3' ' A' ' 10' ' ' LYS . 0.6 OUTLIER -110.43 -23.7 11.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.2 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.51 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.2 mttm -59.95 -37.64 51.34 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.223 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HD3' ' CB ' ' A' ' 7' ' ' LYS . 47.2 Cg_endo -98.99 -44.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.999 1.526 . . . . 0.0 110.382 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.502 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 15.7 mm -54.28 -42.23 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.189 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -60.17 -23.71 64.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.913 . . . . 0.0 110.179 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.79 -42.22 22.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.13 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -18.02 62.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.264 -0.897 . . . . 0.0 110.124 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.183 179.991 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -48.94 -22.1 0.79 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.388 -1.066 . . . . 0.0 110.268 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.898 ' C ' HD13 ' A' ' 9' ' ' ILE . 17.2 tt -103.62 11.31 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 110.203 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -143.27 -45.6 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.224 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -53.67 -54.86 41.47 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 0.0 110.096 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.702 ' HG2' HD12 ' A' ' 9' ' ' ILE . 46.8 Cg_endo -70.96 -40.48 3.41 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.069 1.562 . . . . 0.0 110.275 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.898 HD13 ' C ' ' A' ' 5' ' ' ILE . 2.1 mp -60.23 -40.34 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 1.9 tmtm? -64.42 -40.86 96.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.91 . . . . 0.0 110.223 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -62.29 -57.35 11.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.349 -0.844 . . . . 0.0 110.132 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 mt -115.79 100.73 8.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 110.12 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 -179.904 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.448 ' O ' ' HD2' ' A' ' 8' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.1 tptp -54.9 -17.63 3.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -1.134 . . . . 0.0 110.292 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.863 ' C ' HD13 ' A' ' 9' ' ' ILE . 31.0 pt -127.12 14.67 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -143.27 -37.94 0.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.257 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 3.6 tttt -58.42 -39.72 77.32 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 110.11 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.742 ' HG2' HD12 ' A' ' 9' ' ' ILE . 47.4 Cg_endo -86.32 -48.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.852 1.448 . . . . 0.0 110.212 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.863 HD13 ' C ' ' A' ' 5' ' ' ILE . 2.2 mp -51.01 -24.49 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.143 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.41 -29.41 41.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.917 . . . . 0.0 110.114 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.95 -36.93 19.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.288 -0.883 . . . . 0.0 110.14 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 8' ' ' PRO . 24.3 mt -69.0 -22.01 64.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.307 -0.871 . . . . 0.0 110.247 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.221 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.07 13.18 6.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 110.068 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.883 HD13 ' O ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -122.03 -21.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 110.101 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.468 ' CZ3' HG21 ' A' ' 9' ' ' ILE . 10.7 t-105 -103.87 -7.46 20.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.177 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.499 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -69.24 -41.78 19.14 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.289 -0.882 . . . . 0.0 110.241 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HD3' ' CB ' ' A' ' 7' ' ' LYS . 47.5 Cg_endo -95.3 -35.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.008 1.531 . . . . 0.0 110.335 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.468 HG21 ' CZ3' ' A' ' 6' ' ' TRP . 11.0 mm -59.05 -47.43 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.213 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 8.4 tmtt? -69.7 -30.42 68.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.163 -0.961 . . . . 0.0 110.219 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.652 ' HB3' HD23 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -59.38 -46.98 87.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -0.895 . . . . 0.0 110.23 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.652 HD23 ' HB3' ' A' ' 11' ' ' LYS . 0.8 OUTLIER -167.37 64.29 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.264 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.626 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 O-C-N 121.413 -0.804 . . . . 0.0 110.845 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -61.48 -23.29 65.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -1.144 . . . . 0.0 110.142 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.8 pt -134.96 31.49 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.223 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.514 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -128.05 -40.46 1.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.919 . . . . 0.0 110.101 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.553 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -76.0 -32.56 1.15 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.866 . . . . 0.0 110.058 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 46.6 Cg_endo -97.27 -23.56 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.955 1.503 . . . . 0.0 110.38 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.557 ' CG2' ' N ' ' A' ' 10' ' ' LYS . 3.5 tt -42.34 -44.37 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.895 . . . . 0.0 110.24 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.557 ' N ' ' CG2' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -95.0 -34.34 12.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.308 -0.87 . . . . 0.0 110.398 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HD3' ' O ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -70.43 -39.56 74.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.191 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 12' ' ' LEU . 15.3 mt -101.64 6.05 41.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.937 . . . . 0.0 110.12 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 7' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -75.2 -4.06 36.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -1.124 . . . . 0.0 110.151 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.444 ' C ' HD13 ' A' ' 9' ' ' ILE . 2.5 tp -136.26 5.62 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.206 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 46.8 t-105 -126.57 -43.38 1.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.214 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.552 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 7.0 tttt -56.11 -43.98 99.5 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 110.317 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 46.0 Cg_endo -77.53 -38.84 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.792 1.417 . . . . 0.0 110.494 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.653 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.9 mp -68.05 -14.3 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 109.996 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.65 -26.37 29.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 110.186 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.77 -27.91 10.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.198 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 13' ' ' PHE . 38.5 mt -87.09 -10.82 51.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.239 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.433 ' C ' ' O ' ' A' ' 12' ' ' LEU . 3.8 p90 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.311 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.748 ' HG3' HG23 ' A' ' 5' ' ' ILE . 1.2 pttt -73.4 -9.91 59.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.332 -1.099 . . . . 0.0 110.285 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.748 HG23 ' HG3' ' A' ' 4' ' ' LYS . 1.1 pt -128.25 -4.47 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 110.088 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -93.96 -19.52 20.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.097 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.537 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 16.7 mtpt -73.36 -39.91 5.21 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.33 -0.856 . . . . 0.0 110.202 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.4 Cg_endo -86.74 -40.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.933 1.491 . . . . 0.0 110.469 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 5' ' ' ILE . 13.3 mt -51.55 -31.9 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 110.032 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -94.14 -26.35 16.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 110.052 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -80.19 -6.56 58.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 110.26 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -170.87 40.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.9 . . . . 0.0 110.292 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 9' ' ' ILE . 4.7 t80 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.224 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.406 ' O ' ' HD2' ' A' ' 7' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -81.3 1.52 32.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -1.081 . . . . 0.0 110.146 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.635 ' O ' HD13 ' A' ' 9' ' ' ILE . 14.1 pt -124.74 -11.71 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 110.167 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -103.27 -32.83 9.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 110.039 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.543 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 29.9 mttp -60.91 -54.25 56.16 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 0.0 110.246 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 46.8 Cg_endo -67.44 -31.03 35.27 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.896 1.472 . . . . 0.0 110.308 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 5' ' ' ILE . 1.1 mp -59.56 -26.05 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.656 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.43 -21.67 38.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.817 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -49.91 63.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 110.097 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 12' ' ' LEU . 2.7 mt -74.55 -10.49 59.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.177 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 110.185 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -50.12 -20.97 1.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -1.095 . . . . 0.0 110.356 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.524 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 1.9 tt -144.41 13.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 110.2 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.631 ' CZ3' HG21 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -105.72 -40.06 5.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 110.112 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.544 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 3.5 ttmt -51.71 -54.4 40.3 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.849 . . . . 0.0 110.296 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.0 Cg_endo -67.59 -43.75 5.25 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.923 1.486 . . . . 0.0 110.196 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.631 HG21 ' CZ3' ' A' ' 6' ' ' TRP . 5.7 mm -49.97 -25.87 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.171 -0.956 . . . . 0.0 109.968 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -92.99 -24.2 18.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.888 . . . . 0.0 110.098 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.29 -17.38 64.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.361 -0.837 . . . . 0.0 110.266 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -126.96 15.99 7.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.873 . . . . 0.0 110.117 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 2.5 t80 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 110.241 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -76.8 -7.84 56.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -1.136 . . . . 0.0 110.1 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.503 ' O ' HD13 ' A' ' 9' ' ' ILE . 9.7 tp -142.62 13.83 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.055 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -122.74 -27.07 4.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.06 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.52 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 17.0 mttt -64.52 -42.8 68.25 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.314 -0.867 . . . . 0.0 110.245 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.6 Cg_endo -84.09 -37.61 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.985 1.518 . . . . 0.0 110.441 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.519 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.5 mp -50.43 -46.39 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 0.0 109.904 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.444 ' C ' ' CD ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -66.15 -17.93 65.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.998 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -82.36 -62.77 1.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 110.121 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 12' ' ' LEU . 33.5 mt -53.52 -22.04 7.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.184 -0.948 . . . . 0.0 110.037 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.5 t80 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 110.186 179.981 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.441 ' HA3' ' HB2' ' A' ' 6' ' ' TRP . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -46.42 -23.96 0.44 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -1.059 . . . . 0.0 110.265 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.464 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 5.1 tp -103.81 -1.93 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.216 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.444 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 6.5 m95 -97.46 -33.1 11.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.174 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.545 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -55.59 -36.14 42.33 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 110.036 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 48.2 Cg_endo -92.28 -37.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.985 1.519 . . . . 0.0 110.14 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.464 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 8.1 mt -68.79 -26.11 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.989 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.481 ' O ' ' CD ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -73.32 -29.25 62.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.879 . . . . 0.0 110.102 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -91.84 -39.54 11.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.322 -0.861 . . . . 0.0 110.09 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -56.34 -25.23 48.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 0.0 110.201 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.258 -179.992 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.525 ' O ' ' CD ' ' A' ' 8' ' ' PRO . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.491 ' C ' ' CG1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -79.96 47.69 0.9 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -1.173 . . . . 0.0 109.851 179.419 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.491 ' CG1' ' C ' ' A' ' 4' ' ' LYS . 12.3 mt -152.65 -36.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.313 -0.867 . . . . 0.0 110.292 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.471 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 6.0 t-105 -145.1 -36.57 0.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.063 -1.023 . . . . 0.0 110.857 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.571 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -42.59 -27.43 0.27 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.92 . . . . 0.0 110.423 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.571 ' HD3' ' CB ' ' A' ' 7' ' ' LYS . 48.7 Cg_endo -115.64 -56.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.771 1.406 . . . . 0.0 110.434 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.463 HD12 ' C ' ' A' ' 5' ' ' ILE . 6.6 mt -44.33 -26.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.339 -0.85 . . . . 0.0 110.294 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.488 ' CD ' ' C ' ' A' ' 10' ' ' LYS . 2.9 tmtt? -61.39 -38.36 86.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.892 . . . . 0.0 110.293 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -76.41 -45.76 30.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 110.374 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.1 mt -77.87 -21.84 50.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 110.375 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.193 -0.942 . . . . 0.0 110.255 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -83.4 10.12 9.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -1.152 . . . . 0.0 110.176 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.65 ' O ' HD12 ' A' ' 9' ' ' ILE . 12.4 mt -123.96 -16.99 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 110.259 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -101.36 -24.28 14.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.15 -0.969 . . . . 0.0 109.896 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -78.91 -31.99 0.76 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.848 . . . . 0.0 110.298 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 47.4 Cg_endo -91.1 -34.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.795 1.418 . . . . 0.0 110.407 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.65 HD12 ' O ' ' A' ' 5' ' ' ILE . 5.5 mt -57.23 -57.6 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 109.703 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -56.6 -26.47 55.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.942 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -48.17 55.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 110.147 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.7 mt -91.14 11.63 22.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.4 t80 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.238 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.8 -12.56 17.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -1.105 . . . . 0.0 110.082 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.869 ' O ' HD12 ' A' ' 9' ' ' ILE . 13.1 tt -143.96 40.09 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.001 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 26.6 t-105 -148.12 -37.83 0.19 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.875 . . . . 0.0 110.205 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -63.0 -48.82 83.95 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.345 -0.847 . . . . 0.0 110.253 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.4 Cg_endo -76.14 -36.62 1.82 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.995 1.524 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.869 HD12 ' O ' ' A' ' 5' ' ' ILE . 27.5 mt -65.93 -19.58 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.9 . . . . 0.0 110.062 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -85.51 -30.74 23.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 110.046 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -59.37 2.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.69 -60.7 3.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 0.0 110.227 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 6.1 m-30 . . . . . 0 C--N 1.301 -1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 110.284 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 6' ' ' TRP . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 4' ' ' LYS . 11.2 ttmt -60.33 -13.73 14.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.331 -1.099 . . . . 0.0 110.118 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.643 ' O ' HD12 ' A' ' 9' ' ' ILE . 10.8 mt -135.16 2.47 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.192 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.496 ' HB2' ' HA3' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -90.43 -29.56 17.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 110.184 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.557 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.0 mtmm -67.78 -37.18 11.25 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 110.356 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 48.5 Cg_endo -84.3 -44.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.654 1.344 . . . . 0.0 110.193 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.643 HD12 ' O ' ' A' ' 5' ' ' ILE . 24.7 mt -51.09 -21.82 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.148 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.476 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 5.1 tmtt? -77.47 -34.16 54.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 110.232 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -85.17 -53.38 5.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.879 . . . . 0.0 110.22 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.96 -38.91 58.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.229 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 13.7 m-85 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.375 -0.828 . . . . 0.0 110.182 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.46 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -85.01 -17.22 38.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -1.099 . . . . 0.0 110.151 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.651 ' O ' HD12 ' A' ' 9' ' ' ILE . 21.5 mm -125.73 -7.17 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 109.99 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.95 -27.83 13.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.01 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.567 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 5.1 tttt -74.77 -34.48 1.79 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 110.356 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 48.5 Cg_endo -87.04 -36.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.726 1.382 . . . . 0.0 110.346 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.651 HD12 ' O ' ' A' ' 5' ' ' ILE . 6.1 mt -57.67 -37.08 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 109.876 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -20.86 62.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.98 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -68.94 -54.82 13.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 110.195 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 12' ' ' LEU . 19.4 mt -89.27 28.6 1.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 110.214 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.902 . . . . 0.0 110.179 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' A' ' 6' ' ' TRP . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.45 -24.37 0.5 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -1.207 . . . . 0.0 109.924 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.425 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 24.1 mt -124.31 3.91 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 110.218 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.532 ' CE2' ' HB3' ' A' ' 10' ' ' LYS . 20.4 t-105 -87.54 -25.45 23.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 110.265 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.538 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -52.07 -33.03 9.97 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 110.285 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 47.7 Cg_endo -99.24 -55.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.041 1.548 . . . . 0.0 110.417 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.2 mm -48.55 -56.23 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.284 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.532 ' HB3' ' CE2' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -67.47 -34.1 76.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.042 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.486 ' N ' ' HG3' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -41.63 -59.03 1.75 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.577 -0.702 . . . . 0.0 110.342 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.483 ' HA ' HD23 ' A' ' 12' ' ' LEU . 11.1 mt -76.13 -13.83 60.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.275 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.216 -0.928 . . . . 0.0 110.206 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.44 ' NZ ' HD11 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -45.51 -34.49 3.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.461 -1.023 . . . . 0.0 110.558 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.83 ' O ' HD13 ' A' ' 9' ' ' ILE . 4.4 mt -128.49 26.21 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 110.36 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.56 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -145.75 -35.99 0.29 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 0.0 110.63 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.522 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -57.62 -38.64 69.56 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 110.093 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 7' ' ' LYS . 46.7 Cg_endo -89.78 -49.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.867 1.456 . . . . 0.0 110.058 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.83 HD13 ' O ' ' A' ' 5' ' ' ILE . 1.3 mp -52.43 -20.32 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.837 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.403 ' CD ' ' C ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -66.71 -30.87 71.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 109.969 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -82.21 -31.87 30.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.076 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.16 -25.64 67.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.15 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 110.206 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -73.46 -0.62 15.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.347 -1.09 . . . . 0.0 110.388 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.711 ' O ' HG22 ' A' ' 5' ' ' ILE . 60.1 mt -145.81 20.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 110.012 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -129.08 -26.77 2.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -0.867 . . . . 0.0 110.443 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 9.6 tttp -80.72 -28.15 0.48 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 110.629 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 47.7 Cg_endo -101.12 -27.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.756 1.398 . . . . 0.0 110.672 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.525 HD13 ' HA ' ' A' ' 9' ' ' ILE . 3.5 mm -53.09 -68.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.128 -0.983 . . . . 0.0 110.082 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.469 ' N ' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -63.3 -23.63 67.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 110.407 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 1.8 tttt -71.14 -57.2 4.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.44 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.47 -24.3 59.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.167 -0.958 . . . . 0.0 110.459 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.141 -0.974 . . . . 0.0 110.32 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -76.67 -11.08 59.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.366 -1.079 . . . . 0.0 110.41 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.788 ' C ' HD13 ' A' ' 9' ' ' ILE . 9.8 tt -142.84 24.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.243 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.422 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 46.4 t-105 -137.98 -36.78 0.6 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.89 . . . . 0.0 110.167 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.52 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -48.96 -45.64 74.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 110.092 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.681 ' HG2' HD12 ' A' ' 9' ' ' ILE . 46.6 Cg_endo -91.64 -46.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.073 1.565 . . . . 0.0 110.406 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.788 HD13 ' C ' ' A' ' 5' ' ' ILE . 2.1 mp -50.83 -43.37 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 109.94 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.496 ' C ' ' CD ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -60.1 -18.84 50.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.916 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -26.0 25.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.865 . . . . 0.0 110.161 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -76.2 -22.28 55.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.25 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.161 179.959 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 1' ' ' ILE . 1.5 pt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.22 0.533 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 2' ' ' LEU . 42.8 mt -112.68 -89.51 0.52 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 110.206 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.43 27.36 61.63 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -53.28 -23.0 7.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -1.153 . . . . 0.0 110.212 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.502 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 20.0 tt -133.04 12.03 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.186 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.406 ' O ' ' HB3' ' A' ' 10' ' ' LYS . 0.6 OUTLIER -110.43 -23.7 11.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.2 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.51 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.2 mttm -59.95 -37.64 51.34 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.223 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HD3' ' CB ' ' A' ' 7' ' ' LYS . 47.2 Cg_endo -98.99 -44.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.999 1.526 . . . . 0.0 110.382 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.502 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 15.7 mm -54.28 -42.23 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.189 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -60.17 -23.71 64.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.913 . . . . 0.0 110.179 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.79 -42.22 22.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.13 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -18.02 62.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.264 -0.897 . . . . 0.0 110.124 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -110.83 173.47 6.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.183 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.326 0 O-C-N 119.869 -1.77 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.526 ' O ' HG23 ' A' ' 1' ' ' ILE . 19.8 tt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.22 0.533 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp -65.47 -172.72 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.268 -0.895 . . . . 0.0 110.156 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.66 45.68 1.14 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -48.94 -22.1 0.79 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.388 -1.066 . . . . 0.0 110.268 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.898 ' C ' HD13 ' A' ' 9' ' ' ILE . 17.2 tt -103.62 11.31 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 110.203 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -143.27 -45.6 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.224 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -53.67 -54.86 41.47 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 0.0 110.096 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.702 ' HG2' HD12 ' A' ' 9' ' ' ILE . 46.8 Cg_endo -70.96 -40.48 3.41 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.069 1.562 . . . . 0.0 110.275 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.898 HD13 ' C ' ' A' ' 5' ' ' ILE . 2.1 mp -60.23 -40.34 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 1.9 tmtm? -64.42 -40.86 96.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.91 . . . . 0.0 110.223 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -62.29 -57.35 11.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.349 -0.844 . . . . 0.0 110.132 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 mt -115.79 100.73 8.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 110.12 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -61.65 129.46 41.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.37 0 O-C-N 119.909 -1.744 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 2' ' ' LEU . 2.7 tt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.202 0.525 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 1' ' ' ILE . 63.9 mt 58.5 148.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.366 -0.834 . . . . 0.0 110.392 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.448 ' O ' ' HD2' ' A' ' 8' ' ' PRO . . . 43.65 30.18 1.44 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.1 tptp -54.9 -17.63 3.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -1.134 . . . . 0.0 110.292 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.863 ' C ' HD13 ' A' ' 9' ' ' ILE . 31.0 pt -127.12 14.67 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -143.27 -37.94 0.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.257 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 3.6 tttt -58.42 -39.72 77.32 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 110.11 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.742 ' HG2' HD12 ' A' ' 9' ' ' ILE . 47.4 Cg_endo -86.32 -48.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.852 1.448 . . . . 0.0 110.212 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.863 HD13 ' C ' ' A' ' 5' ' ' ILE . 2.2 mp -51.01 -24.49 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.143 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.41 -29.41 41.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.917 . . . . 0.0 110.114 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.95 -36.93 19.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.288 -0.883 . . . . 0.0 110.14 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 8' ' ' PRO . 24.3 mt -69.0 -22.01 64.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.307 -0.871 . . . . 0.0 110.247 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -90.25 -148.04 0.19 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.221 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.338 0 O-C-N 119.812 -1.805 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.425 ' O ' ' NZ ' ' A' ' 4' ' ' LYS . 2.2 mp . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.266 0.555 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.77 132.02 36.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.92 . . . . 0.0 110.278 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.36 86.02 0.08 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.425 ' NZ ' ' O ' ' A' ' 1' ' ' ILE . 0.0 OUTLIER -85.07 13.18 6.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 110.068 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.883 HD13 ' O ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -122.03 -21.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 110.101 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.468 ' CZ3' HG21 ' A' ' 9' ' ' ILE . 10.7 t-105 -103.87 -7.46 20.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.177 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.499 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -69.24 -41.78 19.14 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.289 -0.882 . . . . 0.0 110.241 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HD3' ' CB ' ' A' ' 7' ' ' LYS . 47.5 Cg_endo -95.3 -35.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.008 1.531 . . . . 0.0 110.335 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.468 HG21 ' CZ3' ' A' ' 6' ' ' TRP . 11.0 mm -59.05 -47.43 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.213 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 8.4 tmtt? -69.7 -30.42 68.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.163 -0.961 . . . . 0.0 110.219 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.652 ' HB3' HD23 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -59.38 -46.98 87.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -0.895 . . . . 0.0 110.23 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.652 HD23 ' HB3' ' A' ' 11' ' ' LYS . 0.8 OUTLIER -167.37 64.29 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.264 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.626 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -53.22 82.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.413 -0.804 . . . . 0.0 110.845 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . 0.523 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.327 0 O-C-N 119.748 -1.845 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 1' ' ' ILE . 11.4 pt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.201 0.524 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.413 HD12 ' H ' ' A' ' 3' ' ' GLY . 0.8 OUTLIER -83.07 -144.83 0.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 110.226 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.413 ' H ' HD12 ' A' ' 2' ' ' LEU . . . 145.71 89.38 0.09 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -61.48 -23.29 65.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -1.144 . . . . 0.0 110.142 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.8 pt -134.96 31.49 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.223 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.514 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -128.05 -40.46 1.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.919 . . . . 0.0 110.101 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.553 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -76.0 -32.56 1.15 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.866 . . . . 0.0 110.058 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 46.6 Cg_endo -97.27 -23.56 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.955 1.503 . . . . 0.0 110.38 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.557 ' CG2' ' N ' ' A' ' 10' ' ' LYS . 3.5 tt -42.34 -44.37 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.895 . . . . 0.0 110.24 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.557 ' N ' ' CG2' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -95.0 -34.34 12.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.308 -0.87 . . . . 0.0 110.398 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HD3' ' O ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -70.43 -39.56 74.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.191 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 12' ' ' LEU . 15.3 mt -101.64 6.05 41.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.937 . . . . 0.0 110.12 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -156.67 101.94 2.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.363 0 O-C-N 119.909 -1.745 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.9 pt . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.237 0.541 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.6 mt -58.49 154.99 12.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.233 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 7' ' ' LYS . . . 51.92 89.49 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -75.2 -4.06 36.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -1.124 . . . . 0.0 110.151 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.444 ' C ' HD13 ' A' ' 9' ' ' ILE . 2.5 tp -136.26 5.62 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.206 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 46.8 t-105 -126.57 -43.38 1.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.214 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.552 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 7.0 tttt -56.11 -43.98 99.5 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 110.317 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 46.0 Cg_endo -77.53 -38.84 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.792 1.417 . . . . 0.0 110.494 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.653 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.9 mp -68.05 -14.3 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 109.996 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.65 -26.37 29.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 110.186 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.77 -27.91 10.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.198 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 13' ' ' PHE . 38.5 mt -87.09 -10.82 51.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.239 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.433 ' C ' ' O ' ' A' ' 12' ' ' LEU . 3.8 p90 -42.13 152.85 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.311 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.343 0 O-C-N 119.867 -1.771 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.848 ' CB ' ' N ' ' A' ' 1' ' ' ILE . . . . . . . . 0 C--O 1.216 -0.693 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.13 136.65 49.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 110.207 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.95 80.54 1.1 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.748 ' HG3' HG23 ' A' ' 5' ' ' ILE . 1.2 pttt -73.4 -9.91 59.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.332 -1.099 . . . . 0.0 110.285 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.748 HG23 ' HG3' ' A' ' 4' ' ' LYS . 1.1 pt -128.25 -4.47 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 110.088 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -93.96 -19.52 20.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.097 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.537 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 16.7 mtpt -73.36 -39.91 5.21 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.33 -0.856 . . . . 0.0 110.202 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.4 Cg_endo -86.74 -40.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.933 1.491 . . . . 0.0 110.469 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 5' ' ' ILE . 13.3 mt -51.55 -31.9 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 110.032 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -94.14 -26.35 16.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 110.052 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -80.19 -6.56 58.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 110.26 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -170.87 40.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.9 . . . . 0.0 110.292 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 9' ' ' ILE . 4.7 t80 -178.45 38.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.224 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.335 0 O-C-N 119.817 -1.802 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.422 ' O ' ' C ' ' A' ' 2' ' ' LEU . 1.5 tp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.182 0.515 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 1' ' ' ILE . 0.2 OUTLIER -42.68 -89.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.23 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.406 ' O ' ' HD2' ' A' ' 7' ' ' LYS . . . 166.73 74.88 0.03 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -81.3 1.52 32.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -1.081 . . . . 0.0 110.146 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.635 ' O ' HD13 ' A' ' 9' ' ' ILE . 14.1 pt -124.74 -11.71 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 110.167 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -103.27 -32.83 9.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 110.039 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.543 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 29.9 mttp -60.91 -54.25 56.16 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 0.0 110.246 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 46.8 Cg_endo -67.44 -31.03 35.27 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.896 1.472 . . . . 0.0 110.308 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 5' ' ' ILE . 1.1 mp -59.56 -26.05 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.656 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.43 -21.67 38.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.817 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -49.91 63.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 110.097 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 12' ' ' LEU . 2.7 mt -74.55 -10.49 59.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.177 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -118.28 29.77 7.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 110.185 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.343 0 O-C-N 119.845 -1.785 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 2' ' ' LEU . 1.5 tt . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.205 0.526 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 1' ' ' ILE . 2.5 mt 56.58 164.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 110.124 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.19 37.07 0.03 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -50.12 -20.97 1.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -1.095 . . . . 0.0 110.356 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.524 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 1.9 tt -144.41 13.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 110.2 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.631 ' CZ3' HG21 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -105.72 -40.06 5.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 110.112 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.544 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 3.5 ttmt -51.71 -54.4 40.3 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.849 . . . . 0.0 110.296 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.0 Cg_endo -67.59 -43.75 5.25 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.923 1.486 . . . . 0.0 110.196 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.631 HG21 ' CZ3' ' A' ' 6' ' ' TRP . 5.7 mm -49.97 -25.87 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.171 -0.956 . . . . 0.0 109.968 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -92.99 -24.2 18.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.888 . . . . 0.0 110.098 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.29 -17.38 64.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.361 -0.837 . . . . 0.0 110.266 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -126.96 15.99 7.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.873 . . . . 0.0 110.117 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 2.5 t80 -140.39 -48.86 0.44 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 110.241 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.331 0 O-C-N 119.865 -1.772 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 1' ' ' ILE . 4.8 mp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.216 0.531 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 1' ' ' ILE . 35.2 mt -144.97 -37.27 0.29 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.331 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.75 90.69 0.08 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -76.8 -7.84 56.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -1.136 . . . . 0.0 110.1 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.503 ' O ' HD13 ' A' ' 9' ' ' ILE . 9.7 tp -142.62 13.83 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.055 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -122.74 -27.07 4.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.06 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.52 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 17.0 mttt -64.52 -42.8 68.25 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.314 -0.867 . . . . 0.0 110.245 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.6 Cg_endo -84.09 -37.61 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.985 1.518 . . . . 0.0 110.441 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.519 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.5 mp -50.43 -46.39 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 0.0 109.904 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.444 ' C ' ' CD ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -66.15 -17.93 65.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.998 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -82.36 -62.77 1.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 110.121 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 12' ' ' LEU . 33.5 mt -53.52 -22.04 7.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.184 -0.948 . . . . 0.0 110.037 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -135.88 56.48 1.82 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 110.186 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.323 0 O-C-N 119.872 -1.767 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 2' ' ' LEU . 3.4 mt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.293 0.568 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 1' ' ' ILE . 6.1 mt 60.54 -84.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.946 . . . . 0.0 110.281 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.441 ' HA3' ' HB2' ' A' ' 6' ' ' TRP . . . -106.44 66.29 0.26 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -46.42 -23.96 0.44 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -1.059 . . . . 0.0 110.265 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.464 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 5.1 tp -103.81 -1.93 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.216 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.444 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 6.5 m95 -97.46 -33.1 11.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.174 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.545 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -55.59 -36.14 42.33 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 110.036 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 48.2 Cg_endo -92.28 -37.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.985 1.519 . . . . 0.0 110.14 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.464 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 8.1 mt -68.79 -26.11 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.989 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.481 ' O ' ' CD ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -73.32 -29.25 62.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.879 . . . . 0.0 110.102 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -91.84 -39.54 11.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.322 -0.861 . . . . 0.0 110.09 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -56.34 -25.23 48.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 0.0 110.201 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -55.8 87.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.258 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . 0.439 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.341 0 O-C-N 119.829 -1.794 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.642 HD12 ' N ' ' A' ' 1' ' ' ILE . 2.3 mp . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.199 0.523 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.449 ' H ' HD12 ' A' ' 2' ' ' LEU . 3.3 mp -42.4 -90.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 110.164 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.525 ' O ' ' CD ' ' A' ' 8' ' ' PRO . . . -162.52 91.19 0.11 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.491 ' C ' ' CG1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -79.96 47.69 0.9 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -1.173 . . . . 0.0 109.851 179.419 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.491 ' CG1' ' C ' ' A' ' 4' ' ' LYS . 12.3 mt -152.65 -36.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.313 -0.867 . . . . 0.0 110.292 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.471 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 6.0 t-105 -145.1 -36.57 0.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.063 -1.023 . . . . 0.0 110.857 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.571 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -42.59 -27.43 0.27 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.92 . . . . 0.0 110.423 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.571 ' HD3' ' CB ' ' A' ' 7' ' ' LYS . 48.7 Cg_endo -115.64 -56.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.771 1.406 . . . . 0.0 110.434 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.463 HD12 ' C ' ' A' ' 5' ' ' ILE . 6.6 mt -44.33 -26.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.339 -0.85 . . . . 0.0 110.294 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.488 ' CD ' ' C ' ' A' ' 10' ' ' LYS . 2.9 tmtt? -61.39 -38.36 86.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.892 . . . . 0.0 110.293 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -76.41 -45.76 30.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 110.374 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.1 mt -77.87 -21.84 50.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 110.375 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -112.36 63.91 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.193 -0.942 . . . . 0.0 110.255 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.355 0 O-C-N 119.845 -1.784 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.456 ' O ' ' N ' ' A' ' 3' ' ' GLY . 3.7 tt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.195 0.522 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 1' ' ' ILE . 0.3 OUTLIER 58.8 -85.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.197 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 1' ' ' ILE . . . 160.5 104.78 0.2 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -83.4 10.12 9.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -1.152 . . . . 0.0 110.176 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.65 ' O ' HD12 ' A' ' 9' ' ' ILE . 12.4 mt -123.96 -16.99 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 110.259 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -101.36 -24.28 14.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.15 -0.969 . . . . 0.0 109.896 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -78.91 -31.99 0.76 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.848 . . . . 0.0 110.298 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 47.4 Cg_endo -91.1 -34.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.795 1.418 . . . . 0.0 110.407 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.65 HD12 ' O ' ' A' ' 5' ' ' ILE . 5.5 mt -57.23 -57.6 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 109.703 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -56.6 -26.47 55.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.942 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -48.17 55.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 110.147 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.7 mt -91.14 11.63 22.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.4 t80 -81.58 -40.85 22.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.238 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.352 0 O-C-N 119.826 -1.797 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.66 ' N ' HD12 ' A' ' 1' ' ' ILE . 2.4 mp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.249 0.547 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.404 ' HB3' ' HE3' ' A' ' 7' ' ' LYS . 2.4 mt 50.42 -89.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.237 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 1' ' ' ILE . . . -122.13 71.8 0.39 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.8 -12.56 17.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -1.105 . . . . 0.0 110.082 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.869 ' O ' HD12 ' A' ' 9' ' ' ILE . 13.1 tt -143.96 40.09 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.001 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 26.6 t-105 -148.12 -37.83 0.19 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.875 . . . . 0.0 110.205 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -63.0 -48.82 83.95 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.345 -0.847 . . . . 0.0 110.253 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.4 Cg_endo -76.14 -36.62 1.82 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.995 1.524 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.869 HD12 ' O ' ' A' ' 5' ' ' ILE . 27.5 mt -65.93 -19.58 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.9 . . . . 0.0 110.062 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -85.51 -30.74 23.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 110.046 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -59.37 2.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.69 -60.7 3.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 0.0 110.227 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 6.1 m-30 -79.84 -150.7 0.06 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 110.284 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.345 0 O-C-N 119.825 -1.797 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.415 ' C ' ' HG ' ' A' ' 2' ' ' LEU . 52.2 mt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.29 0.567 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.415 ' HG ' ' C ' ' A' ' 1' ' ' ILE . 3.6 mt -127.82 126.53 41.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 6' ' ' TRP . . . 84.27 89.6 0.8 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 4' ' ' LYS . 11.2 ttmt -60.33 -13.73 14.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.331 -1.099 . . . . 0.0 110.118 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.643 ' O ' HD12 ' A' ' 9' ' ' ILE . 10.8 mt -135.16 2.47 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.192 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.496 ' HB2' ' HA3' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -90.43 -29.56 17.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 110.184 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.557 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.0 mtmm -67.78 -37.18 11.25 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 110.356 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 48.5 Cg_endo -84.3 -44.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.654 1.344 . . . . 0.0 110.193 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.643 HD12 ' O ' ' A' ' 5' ' ' ILE . 24.7 mt -51.09 -21.82 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.148 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.476 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 5.1 tmtt? -77.47 -34.16 54.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 110.232 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -85.17 -53.38 5.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.879 . . . . 0.0 110.22 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.96 -38.91 58.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.229 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 13.7 m-85 -106.62 168.72 8.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.375 -0.828 . . . . 0.0 110.182 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.32 0 O-C-N 119.867 -1.77 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 42.9 mt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.251 0.548 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 mt 51.9 -164.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.223 -0.923 . . . . 0.0 110.258 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 112.1 82.71 1.24 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.46 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -85.01 -17.22 38.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -1.099 . . . . 0.0 110.151 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.651 ' O ' HD12 ' A' ' 9' ' ' ILE . 21.5 mm -125.73 -7.17 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 109.99 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.95 -27.83 13.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.01 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.567 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 5.1 tttt -74.77 -34.48 1.79 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 110.356 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 48.5 Cg_endo -87.04 -36.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.726 1.382 . . . . 0.0 110.346 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.651 HD12 ' O ' ' A' ' 5' ' ' ILE . 6.1 mt -57.67 -37.08 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 109.876 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -20.86 62.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.98 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -68.94 -54.82 13.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 110.195 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 12' ' ' LEU . 19.4 mt -89.27 28.6 1.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 110.214 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -106.26 -153.68 0.5 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.902 . . . . 0.0 110.179 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.358 0 O-C-N 119.89 -1.756 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 2' ' ' LEU . 20.1 pt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.233 0.54 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 1' ' ' ILE . 1.5 mt -55.83 -163.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.185 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' A' ' 6' ' ' TRP . . . -78.39 0.06 76.59 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.45 -24.37 0.5 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -1.207 . . . . 0.0 109.924 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.425 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 24.1 mt -124.31 3.91 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 110.218 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.532 ' CE2' ' HB3' ' A' ' 10' ' ' LYS . 20.4 t-105 -87.54 -25.45 23.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 110.265 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.538 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -52.07 -33.03 9.97 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 110.285 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 47.7 Cg_endo -99.24 -55.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.041 1.548 . . . . 0.0 110.417 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.2 mm -48.55 -56.23 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.284 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.532 ' HB3' ' CE2' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -67.47 -34.1 76.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.042 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.486 ' N ' ' HG3' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -41.63 -59.03 1.75 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.577 -0.702 . . . . 0.0 110.342 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.483 ' HA ' HD23 ' A' ' 12' ' ' LEU . 11.1 mt -76.13 -13.83 60.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.275 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.27 -83.29 0.61 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.216 -0.928 . . . . 0.0 110.206 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . 0.418 ' N ' ' O ' ' A' ' 10' ' ' LYS . . . . . . . . 0 C--N 1.306 -1.326 0 O-C-N 119.876 -1.765 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.475 ' HA ' HD13 ' A' ' 1' ' ' ILE . 13.1 mm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.257 0.551 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.87 160.75 14.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.197 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.79 70.09 0.24 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.44 ' NZ ' HD11 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -45.51 -34.49 3.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.461 -1.023 . . . . 0.0 110.558 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.83 ' O ' HD13 ' A' ' 9' ' ' ILE . 4.4 mt -128.49 26.21 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 110.36 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.56 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -145.75 -35.99 0.29 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 0.0 110.63 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.522 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -57.62 -38.64 69.56 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 110.093 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 7' ' ' LYS . 46.7 Cg_endo -89.78 -49.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.867 1.456 . . . . 0.0 110.058 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.83 HD13 ' O ' ' A' ' 5' ' ' ILE . 1.3 mp -52.43 -20.32 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.837 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.403 ' CD ' ' C ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -66.71 -30.87 71.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 109.969 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -82.21 -31.87 30.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.076 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.16 -25.64 67.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.15 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.13 161.79 10.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 110.206 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.367 0 O-C-N 119.855 -1.778 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.741 HD12 ' C ' ' A' ' 1' ' ' ILE . 2.6 pp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.221 0.534 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 46.4 mt -108.82 -169.86 1.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 110.134 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 49.44 77.89 0.11 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -73.46 -0.62 15.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.347 -1.09 . . . . 0.0 110.388 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.711 ' O ' HG22 ' A' ' 5' ' ' ILE . 60.1 mt -145.81 20.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 110.012 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -129.08 -26.77 2.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -0.867 . . . . 0.0 110.443 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 9.6 tttp -80.72 -28.15 0.48 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 110.629 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 47.7 Cg_endo -101.12 -27.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.756 1.398 . . . . 0.0 110.672 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.525 HD13 ' HA ' ' A' ' 9' ' ' ILE . 3.5 mm -53.09 -68.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.128 -0.983 . . . . 0.0 110.082 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.469 ' N ' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -63.3 -23.63 67.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 110.407 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 1.8 tttt -71.14 -57.2 4.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.44 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.47 -24.3 59.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.167 -0.958 . . . . 0.0 110.459 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.0 106.88 19.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.141 -0.974 . . . . 0.0 110.32 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 119.94 -1.725 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 6.4 mt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.206 0.527 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.412 ' H ' HD23 ' A' ' 2' ' ' LEU . 0.5 OUTLIER -82.99 -160.63 0.42 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 110.276 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 156.72 77.02 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -76.67 -11.08 59.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.366 -1.079 . . . . 0.0 110.41 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.788 ' C ' HD13 ' A' ' 9' ' ' ILE . 9.8 tt -142.84 24.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.243 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.422 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 46.4 t-105 -137.98 -36.78 0.6 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.89 . . . . 0.0 110.167 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.52 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -48.96 -45.64 74.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 110.092 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.681 ' HG2' HD12 ' A' ' 9' ' ' ILE . 46.6 Cg_endo -91.64 -46.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.073 1.565 . . . . 0.0 110.406 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.788 HD13 ' C ' ' A' ' 5' ' ' ILE . 2.1 mp -50.83 -43.37 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 109.94 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.496 ' C ' ' CD ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -60.1 -18.84 50.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.916 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -26.0 25.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.865 . . . . 0.0 110.161 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -76.2 -22.28 55.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.25 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -58.47 -177.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.161 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.367 0 O-C-N 119.877 -1.765 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -53.28 -23.0 7.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -1.153 . . . . 0.0 110.212 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.502 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 20.0 tt -133.04 12.03 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.186 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.406 ' O ' ' HB3' ' A' ' 10' ' ' LYS . 0.6 OUTLIER -110.43 -23.7 11.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.2 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.51 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.2 mttm -59.95 -37.64 51.34 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.223 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HD3' ' CB ' ' A' ' 7' ' ' LYS . 47.2 Cg_endo -98.99 -44.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.999 1.526 . . . . 0.0 110.382 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.502 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 15.7 mm -54.28 -42.23 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.189 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -60.17 -23.71 64.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.913 . . . . 0.0 110.179 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.79 -42.22 22.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.13 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -18.02 62.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.264 -0.897 . . . . 0.0 110.124 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.183 179.991 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -48.94 -22.1 0.79 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.388 -1.066 . . . . 0.0 110.268 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.898 ' C ' HD13 ' A' ' 9' ' ' ILE . 17.2 tt -103.62 11.31 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 110.203 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -143.27 -45.6 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.224 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -53.67 -54.86 41.47 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 0.0 110.096 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.702 ' HG2' HD12 ' A' ' 9' ' ' ILE . 46.8 Cg_endo -70.96 -40.48 3.41 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.069 1.562 . . . . 0.0 110.275 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.898 HD13 ' C ' ' A' ' 5' ' ' ILE . 2.1 mp -60.23 -40.34 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 1.9 tmtm? -64.42 -40.86 96.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.91 . . . . 0.0 110.223 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -62.29 -57.35 11.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.349 -0.844 . . . . 0.0 110.132 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 mt -115.79 100.73 8.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 110.12 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 -179.904 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.448 ' O ' ' HD2' ' A' ' 8' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.1 tptp -54.9 -17.63 3.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -1.134 . . . . 0.0 110.292 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.863 ' C ' HD13 ' A' ' 9' ' ' ILE . 31.0 pt -127.12 14.67 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -143.27 -37.94 0.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.257 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 3.6 tttt -58.42 -39.72 77.32 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 110.11 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.742 ' HG2' HD12 ' A' ' 9' ' ' ILE . 47.4 Cg_endo -86.32 -48.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.852 1.448 . . . . 0.0 110.212 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.863 HD13 ' C ' ' A' ' 5' ' ' ILE . 2.2 mp -51.01 -24.49 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.143 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.41 -29.41 41.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.917 . . . . 0.0 110.114 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.95 -36.93 19.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.288 -0.883 . . . . 0.0 110.14 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 8' ' ' PRO . 24.3 mt -69.0 -22.01 64.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.307 -0.871 . . . . 0.0 110.247 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.221 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.07 13.18 6.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 110.068 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.883 HD13 ' O ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -122.03 -21.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 110.101 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.468 ' CZ3' HG21 ' A' ' 9' ' ' ILE . 10.7 t-105 -103.87 -7.46 20.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.177 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.499 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -69.24 -41.78 19.14 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.289 -0.882 . . . . 0.0 110.241 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HD3' ' CB ' ' A' ' 7' ' ' LYS . 47.5 Cg_endo -95.3 -35.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.008 1.531 . . . . 0.0 110.335 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.468 HG21 ' CZ3' ' A' ' 6' ' ' TRP . 11.0 mm -59.05 -47.43 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.213 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 8.4 tmtt? -69.7 -30.42 68.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.163 -0.961 . . . . 0.0 110.219 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.652 ' HB3' HD23 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -59.38 -46.98 87.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -0.895 . . . . 0.0 110.23 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.652 HD23 ' HB3' ' A' ' 11' ' ' LYS . 0.8 OUTLIER -167.37 64.29 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.264 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.626 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 O-C-N 121.413 -0.804 . . . . 0.0 110.845 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -61.48 -23.29 65.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -1.144 . . . . 0.0 110.142 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.8 pt -134.96 31.49 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.223 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.514 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -128.05 -40.46 1.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.919 . . . . 0.0 110.101 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.553 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -76.0 -32.56 1.15 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.866 . . . . 0.0 110.058 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 46.6 Cg_endo -97.27 -23.56 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.955 1.503 . . . . 0.0 110.38 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.557 ' CG2' ' N ' ' A' ' 10' ' ' LYS . 3.5 tt -42.34 -44.37 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.895 . . . . 0.0 110.24 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.557 ' N ' ' CG2' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -95.0 -34.34 12.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.308 -0.87 . . . . 0.0 110.398 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HD3' ' O ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -70.43 -39.56 74.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.191 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 12' ' ' LEU . 15.3 mt -101.64 6.05 41.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.937 . . . . 0.0 110.12 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 7' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -75.2 -4.06 36.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -1.124 . . . . 0.0 110.151 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.444 ' C ' HD13 ' A' ' 9' ' ' ILE . 2.5 tp -136.26 5.62 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.206 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 46.8 t-105 -126.57 -43.38 1.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.214 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.552 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 7.0 tttt -56.11 -43.98 99.5 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 110.317 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 46.0 Cg_endo -77.53 -38.84 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.792 1.417 . . . . 0.0 110.494 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.653 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.9 mp -68.05 -14.3 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 109.996 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.65 -26.37 29.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 110.186 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.77 -27.91 10.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.198 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 13' ' ' PHE . 38.5 mt -87.09 -10.82 51.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.239 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.433 ' C ' ' O ' ' A' ' 12' ' ' LEU . 3.8 p90 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.311 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.748 ' HG3' HG23 ' A' ' 5' ' ' ILE . 1.2 pttt -73.4 -9.91 59.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.332 -1.099 . . . . 0.0 110.285 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.748 HG23 ' HG3' ' A' ' 4' ' ' LYS . 1.1 pt -128.25 -4.47 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 110.088 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -93.96 -19.52 20.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.097 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.537 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 16.7 mtpt -73.36 -39.91 5.21 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.33 -0.856 . . . . 0.0 110.202 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.4 Cg_endo -86.74 -40.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.933 1.491 . . . . 0.0 110.469 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 5' ' ' ILE . 13.3 mt -51.55 -31.9 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 110.032 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -94.14 -26.35 16.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 110.052 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -80.19 -6.56 58.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 110.26 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -170.87 40.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.9 . . . . 0.0 110.292 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 9' ' ' ILE . 4.7 t80 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.224 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.406 ' O ' ' HD2' ' A' ' 7' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -81.3 1.52 32.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -1.081 . . . . 0.0 110.146 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.635 ' O ' HD13 ' A' ' 9' ' ' ILE . 14.1 pt -124.74 -11.71 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 110.167 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -103.27 -32.83 9.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 110.039 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.543 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 29.9 mttp -60.91 -54.25 56.16 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 0.0 110.246 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 46.8 Cg_endo -67.44 -31.03 35.27 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.896 1.472 . . . . 0.0 110.308 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 5' ' ' ILE . 1.1 mp -59.56 -26.05 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.656 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.43 -21.67 38.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.817 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -49.91 63.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 110.097 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 12' ' ' LEU . 2.7 mt -74.55 -10.49 59.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.177 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 110.185 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -50.12 -20.97 1.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -1.095 . . . . 0.0 110.356 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.524 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 1.9 tt -144.41 13.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 110.2 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.631 ' CZ3' HG21 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -105.72 -40.06 5.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 110.112 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.544 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 3.5 ttmt -51.71 -54.4 40.3 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.849 . . . . 0.0 110.296 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.0 Cg_endo -67.59 -43.75 5.25 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.923 1.486 . . . . 0.0 110.196 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.631 HG21 ' CZ3' ' A' ' 6' ' ' TRP . 5.7 mm -49.97 -25.87 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.171 -0.956 . . . . 0.0 109.968 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -92.99 -24.2 18.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.888 . . . . 0.0 110.098 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.29 -17.38 64.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.361 -0.837 . . . . 0.0 110.266 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -126.96 15.99 7.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.873 . . . . 0.0 110.117 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 2.5 t80 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 110.241 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -76.8 -7.84 56.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -1.136 . . . . 0.0 110.1 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.503 ' O ' HD13 ' A' ' 9' ' ' ILE . 9.7 tp -142.62 13.83 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.055 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -122.74 -27.07 4.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.06 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.52 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 17.0 mttt -64.52 -42.8 68.25 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.314 -0.867 . . . . 0.0 110.245 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.6 Cg_endo -84.09 -37.61 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.985 1.518 . . . . 0.0 110.441 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.519 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.5 mp -50.43 -46.39 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 0.0 109.904 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.444 ' C ' ' CD ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -66.15 -17.93 65.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.998 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -82.36 -62.77 1.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 110.121 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 12' ' ' LEU . 33.5 mt -53.52 -22.04 7.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.184 -0.948 . . . . 0.0 110.037 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.5 t80 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 110.186 179.981 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.441 ' HA3' ' HB2' ' A' ' 6' ' ' TRP . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -46.42 -23.96 0.44 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -1.059 . . . . 0.0 110.265 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.464 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 5.1 tp -103.81 -1.93 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.216 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.444 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 6.5 m95 -97.46 -33.1 11.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.174 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.545 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -55.59 -36.14 42.33 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 110.036 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 48.2 Cg_endo -92.28 -37.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.985 1.519 . . . . 0.0 110.14 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.464 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 8.1 mt -68.79 -26.11 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.989 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.481 ' O ' ' CD ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -73.32 -29.25 62.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.879 . . . . 0.0 110.102 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -91.84 -39.54 11.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.322 -0.861 . . . . 0.0 110.09 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -56.34 -25.23 48.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 0.0 110.201 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.258 -179.992 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.525 ' O ' ' CD ' ' A' ' 8' ' ' PRO . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.491 ' C ' ' CG1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -79.96 47.69 0.9 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -1.173 . . . . 0.0 109.851 179.419 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.491 ' CG1' ' C ' ' A' ' 4' ' ' LYS . 12.3 mt -152.65 -36.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.313 -0.867 . . . . 0.0 110.292 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.471 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 6.0 t-105 -145.1 -36.57 0.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.063 -1.023 . . . . 0.0 110.857 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.571 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -42.59 -27.43 0.27 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.92 . . . . 0.0 110.423 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.571 ' HD3' ' CB ' ' A' ' 7' ' ' LYS . 48.7 Cg_endo -115.64 -56.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.771 1.406 . . . . 0.0 110.434 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.463 HD12 ' C ' ' A' ' 5' ' ' ILE . 6.6 mt -44.33 -26.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.339 -0.85 . . . . 0.0 110.294 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.488 ' CD ' ' C ' ' A' ' 10' ' ' LYS . 2.9 tmtt? -61.39 -38.36 86.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.892 . . . . 0.0 110.293 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -76.41 -45.76 30.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 110.374 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.1 mt -77.87 -21.84 50.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 110.375 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.193 -0.942 . . . . 0.0 110.255 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -83.4 10.12 9.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -1.152 . . . . 0.0 110.176 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.65 ' O ' HD12 ' A' ' 9' ' ' ILE . 12.4 mt -123.96 -16.99 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 110.259 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -101.36 -24.28 14.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.15 -0.969 . . . . 0.0 109.896 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -78.91 -31.99 0.76 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.848 . . . . 0.0 110.298 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 47.4 Cg_endo -91.1 -34.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.795 1.418 . . . . 0.0 110.407 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.65 HD12 ' O ' ' A' ' 5' ' ' ILE . 5.5 mt -57.23 -57.6 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 109.703 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -56.6 -26.47 55.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.942 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -48.17 55.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 110.147 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.7 mt -91.14 11.63 22.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.4 t80 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.238 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.8 -12.56 17.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -1.105 . . . . 0.0 110.082 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.869 ' O ' HD12 ' A' ' 9' ' ' ILE . 13.1 tt -143.96 40.09 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.001 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 26.6 t-105 -148.12 -37.83 0.19 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.875 . . . . 0.0 110.205 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -63.0 -48.82 83.95 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.345 -0.847 . . . . 0.0 110.253 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.4 Cg_endo -76.14 -36.62 1.82 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.995 1.524 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.869 HD12 ' O ' ' A' ' 5' ' ' ILE . 27.5 mt -65.93 -19.58 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.9 . . . . 0.0 110.062 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -85.51 -30.74 23.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 110.046 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -59.37 2.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.69 -60.7 3.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 0.0 110.227 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 6.1 m-30 . . . . . 0 C--N 1.301 -1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 110.284 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 6' ' ' TRP . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 4' ' ' LYS . 11.2 ttmt -60.33 -13.73 14.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.331 -1.099 . . . . 0.0 110.118 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.643 ' O ' HD12 ' A' ' 9' ' ' ILE . 10.8 mt -135.16 2.47 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.192 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.496 ' HB2' ' HA3' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -90.43 -29.56 17.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 110.184 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.557 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.0 mtmm -67.78 -37.18 11.25 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 110.356 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 48.5 Cg_endo -84.3 -44.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.654 1.344 . . . . 0.0 110.193 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.643 HD12 ' O ' ' A' ' 5' ' ' ILE . 24.7 mt -51.09 -21.82 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.148 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.476 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 5.1 tmtt? -77.47 -34.16 54.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 110.232 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -85.17 -53.38 5.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.879 . . . . 0.0 110.22 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.96 -38.91 58.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.229 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 13.7 m-85 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.375 -0.828 . . . . 0.0 110.182 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.46 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -85.01 -17.22 38.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -1.099 . . . . 0.0 110.151 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.651 ' O ' HD12 ' A' ' 9' ' ' ILE . 21.5 mm -125.73 -7.17 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 109.99 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.95 -27.83 13.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.01 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.567 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 5.1 tttt -74.77 -34.48 1.79 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 110.356 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 48.5 Cg_endo -87.04 -36.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.726 1.382 . . . . 0.0 110.346 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.651 HD12 ' O ' ' A' ' 5' ' ' ILE . 6.1 mt -57.67 -37.08 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 109.876 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -20.86 62.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.98 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -68.94 -54.82 13.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 110.195 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 12' ' ' LEU . 19.4 mt -89.27 28.6 1.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 110.214 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.902 . . . . 0.0 110.179 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' A' ' 6' ' ' TRP . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.45 -24.37 0.5 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -1.207 . . . . 0.0 109.924 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.425 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 24.1 mt -124.31 3.91 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 110.218 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.532 ' CE2' ' HB3' ' A' ' 10' ' ' LYS . 20.4 t-105 -87.54 -25.45 23.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 110.265 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.538 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -52.07 -33.03 9.97 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 110.285 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 47.7 Cg_endo -99.24 -55.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.041 1.548 . . . . 0.0 110.417 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.2 mm -48.55 -56.23 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.284 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.532 ' HB3' ' CE2' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -67.47 -34.1 76.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.042 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.486 ' N ' ' HG3' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -41.63 -59.03 1.75 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.577 -0.702 . . . . 0.0 110.342 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.483 ' HA ' HD23 ' A' ' 12' ' ' LEU . 11.1 mt -76.13 -13.83 60.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.275 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.216 -0.928 . . . . 0.0 110.206 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.44 ' NZ ' HD11 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -45.51 -34.49 3.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.461 -1.023 . . . . 0.0 110.558 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.83 ' O ' HD13 ' A' ' 9' ' ' ILE . 4.4 mt -128.49 26.21 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 110.36 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.56 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -145.75 -35.99 0.29 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 0.0 110.63 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.522 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -57.62 -38.64 69.56 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 110.093 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 7' ' ' LYS . 46.7 Cg_endo -89.78 -49.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.867 1.456 . . . . 0.0 110.058 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.83 HD13 ' O ' ' A' ' 5' ' ' ILE . 1.3 mp -52.43 -20.32 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.837 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.403 ' CD ' ' C ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -66.71 -30.87 71.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 109.969 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -82.21 -31.87 30.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.076 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.16 -25.64 67.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.15 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 110.206 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -73.46 -0.62 15.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.347 -1.09 . . . . 0.0 110.388 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.711 ' O ' HG22 ' A' ' 5' ' ' ILE . 60.1 mt -145.81 20.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 110.012 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -129.08 -26.77 2.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -0.867 . . . . 0.0 110.443 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 9.6 tttp -80.72 -28.15 0.48 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 110.629 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 47.7 Cg_endo -101.12 -27.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.756 1.398 . . . . 0.0 110.672 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.525 HD13 ' HA ' ' A' ' 9' ' ' ILE . 3.5 mm -53.09 -68.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.128 -0.983 . . . . 0.0 110.082 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.469 ' N ' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -63.3 -23.63 67.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 110.407 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 1.8 tttt -71.14 -57.2 4.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.44 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.47 -24.3 59.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.167 -0.958 . . . . 0.0 110.459 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.141 -0.974 . . . . 0.0 110.32 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -76.67 -11.08 59.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.366 -1.079 . . . . 0.0 110.41 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.788 ' C ' HD13 ' A' ' 9' ' ' ILE . 9.8 tt -142.84 24.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.243 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.422 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 46.4 t-105 -137.98 -36.78 0.6 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.89 . . . . 0.0 110.167 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.52 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -48.96 -45.64 74.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 110.092 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.681 ' HG2' HD12 ' A' ' 9' ' ' ILE . 46.6 Cg_endo -91.64 -46.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.073 1.565 . . . . 0.0 110.406 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.788 HD13 ' C ' ' A' ' 5' ' ' ILE . 2.1 mp -50.83 -43.37 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 109.94 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.496 ' C ' ' CD ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -60.1 -18.84 50.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.916 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -26.0 25.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.865 . . . . 0.0 110.161 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -76.2 -22.28 55.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.25 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.161 179.959 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 1' ' ' ILE . 1.5 pt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.22 0.533 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 2' ' ' LEU . 42.8 mt -112.68 -89.51 0.52 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 110.206 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.43 27.36 61.63 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -53.28 -23.0 7.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -1.153 . . . . 0.0 110.212 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.502 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 20.0 tt -133.04 12.03 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.0 110.186 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.406 ' O ' ' HB3' ' A' ' 10' ' ' LYS . 0.6 OUTLIER -110.43 -23.7 11.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 110.2 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.51 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 1.2 mttm -59.95 -37.64 51.34 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.901 . . . . 0.0 110.223 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.51 ' HD3' ' CB ' ' A' ' 7' ' ' LYS . 47.2 Cg_endo -98.99 -44.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.999 1.526 . . . . 0.0 110.382 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.502 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 15.7 mm -54.28 -42.23 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.189 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -60.17 -23.71 64.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.913 . . . . 0.0 110.179 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.79 -42.22 22.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.13 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.51 -18.02 62.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.264 -0.897 . . . . 0.0 110.124 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -110.83 173.47 6.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 110.183 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.326 0 O-C-N 119.869 -1.77 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.526 ' O ' HG23 ' A' ' 1' ' ' ILE . 19.8 tt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.22 0.533 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp -65.47 -172.72 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.268 -0.895 . . . . 0.0 110.156 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -125.66 45.68 1.14 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -48.94 -22.1 0.79 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.388 -1.066 . . . . 0.0 110.268 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.898 ' C ' HD13 ' A' ' 9' ' ' ILE . 17.2 tt -103.62 11.31 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 110.203 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -143.27 -45.6 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.224 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -53.67 -54.86 41.47 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 0.0 110.096 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.702 ' HG2' HD12 ' A' ' 9' ' ' ILE . 46.8 Cg_endo -70.96 -40.48 3.41 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.069 1.562 . . . . 0.0 110.275 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.898 HD13 ' C ' ' A' ' 5' ' ' ILE . 2.1 mp -60.23 -40.34 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.146 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 1.9 tmtm? -64.42 -40.86 96.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.91 . . . . 0.0 110.223 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -62.29 -57.35 11.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.349 -0.844 . . . . 0.0 110.132 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 mt -115.79 100.73 8.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.86 . . . . 0.0 110.12 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -61.65 129.46 41.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 110.237 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.37 0 O-C-N 119.909 -1.744 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 2' ' ' LEU . 2.7 tt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.202 0.525 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 1' ' ' ILE . 63.9 mt 58.5 148.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.366 -0.834 . . . . 0.0 110.392 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.448 ' O ' ' HD2' ' A' ' 8' ' ' PRO . . . 43.65 30.18 1.44 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.1 tptp -54.9 -17.63 3.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -1.134 . . . . 0.0 110.292 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.863 ' C ' HD13 ' A' ' 9' ' ' ILE . 31.0 pt -127.12 14.67 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -143.27 -37.94 0.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.257 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 3.6 tttt -58.42 -39.72 77.32 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 110.11 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.742 ' HG2' HD12 ' A' ' 9' ' ' ILE . 47.4 Cg_endo -86.32 -48.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.852 1.448 . . . . 0.0 110.212 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.863 HD13 ' C ' ' A' ' 5' ' ' ILE . 2.2 mp -51.01 -24.49 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.143 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.41 -29.41 41.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.917 . . . . 0.0 110.114 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.95 -36.93 19.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.288 -0.883 . . . . 0.0 110.14 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 8' ' ' PRO . 24.3 mt -69.0 -22.01 64.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.307 -0.871 . . . . 0.0 110.247 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -90.25 -148.04 0.19 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.204 -0.935 . . . . 0.0 110.221 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.338 0 O-C-N 119.812 -1.805 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.425 ' O ' ' NZ ' ' A' ' 4' ' ' LYS . 2.2 mp . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.266 0.555 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.77 132.02 36.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.92 . . . . 0.0 110.278 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.36 86.02 0.08 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.425 ' NZ ' ' O ' ' A' ' 1' ' ' ILE . 0.0 OUTLIER -85.07 13.18 6.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -1.13 . . . . 0.0 110.068 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.883 HD13 ' O ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -122.03 -21.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 0.0 110.101 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.468 ' CZ3' HG21 ' A' ' 9' ' ' ILE . 10.7 t-105 -103.87 -7.46 20.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.177 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.499 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -69.24 -41.78 19.14 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.289 -0.882 . . . . 0.0 110.241 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HD3' ' CB ' ' A' ' 7' ' ' LYS . 47.5 Cg_endo -95.3 -35.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.008 1.531 . . . . 0.0 110.335 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.468 HG21 ' CZ3' ' A' ' 6' ' ' TRP . 11.0 mm -59.05 -47.43 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 110.213 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 8.4 tmtt? -69.7 -30.42 68.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.163 -0.961 . . . . 0.0 110.219 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.652 ' HB3' HD23 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -59.38 -46.98 87.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.269 -0.895 . . . . 0.0 110.23 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.652 HD23 ' HB3' ' A' ' 11' ' ' LYS . 0.8 OUTLIER -167.37 64.29 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.264 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.626 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -53.22 82.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.413 -0.804 . . . . 0.0 110.845 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . 0.523 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.327 0 O-C-N 119.748 -1.845 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 1' ' ' ILE . 11.4 pt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.201 0.524 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.413 HD12 ' H ' ' A' ' 3' ' ' GLY . 0.8 OUTLIER -83.07 -144.83 0.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 110.226 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.413 ' H ' HD12 ' A' ' 2' ' ' LEU . . . 145.71 89.38 0.09 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -61.48 -23.29 65.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -1.144 . . . . 0.0 110.142 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.8 pt -134.96 31.49 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.223 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.514 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -128.05 -40.46 1.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.919 . . . . 0.0 110.101 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.553 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -76.0 -32.56 1.15 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.315 -0.866 . . . . 0.0 110.058 179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 46.6 Cg_endo -97.27 -23.56 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.955 1.503 . . . . 0.0 110.38 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.557 ' CG2' ' N ' ' A' ' 10' ' ' LYS . 3.5 tt -42.34 -44.37 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.895 . . . . 0.0 110.24 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.557 ' N ' ' CG2' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -95.0 -34.34 12.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.308 -0.87 . . . . 0.0 110.398 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HD3' ' O ' ' A' ' 7' ' ' LYS . 0.3 OUTLIER -70.43 -39.56 74.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.191 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 12' ' ' LEU . 15.3 mt -101.64 6.05 41.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.2 -0.937 . . . . 0.0 110.12 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -156.67 101.94 2.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.178 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.363 0 O-C-N 119.909 -1.745 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.9 pt . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.237 0.541 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.6 mt -58.49 154.99 12.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 110.233 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 7' ' ' LYS . . . 51.92 89.49 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -75.2 -4.06 36.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -1.124 . . . . 0.0 110.151 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.444 ' C ' HD13 ' A' ' 9' ' ' ILE . 2.5 tp -136.26 5.62 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.206 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 46.8 t-105 -126.57 -43.38 1.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.214 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.552 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 7.0 tttt -56.11 -43.98 99.5 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 110.317 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 46.0 Cg_endo -77.53 -38.84 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.792 1.417 . . . . 0.0 110.494 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.653 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.9 mp -68.05 -14.3 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 109.996 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.65 -26.37 29.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 110.186 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.77 -27.91 10.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.198 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 13' ' ' PHE . 38.5 mt -87.09 -10.82 51.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 110.239 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.433 ' C ' ' O ' ' A' ' 12' ' ' LEU . 3.8 p90 -42.13 152.85 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.311 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.343 0 O-C-N 119.867 -1.771 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.848 ' CB ' ' N ' ' A' ' 1' ' ' ILE . . . . . . . . 0 C--O 1.216 -0.693 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.13 136.65 49.53 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 110.207 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.95 80.54 1.1 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.748 ' HG3' HG23 ' A' ' 5' ' ' ILE . 1.2 pttt -73.4 -9.91 59.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.332 -1.099 . . . . 0.0 110.285 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.748 HG23 ' HG3' ' A' ' 4' ' ' LYS . 1.1 pt -128.25 -4.47 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.0 110.088 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -93.96 -19.52 20.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.097 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.537 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 16.7 mtpt -73.36 -39.91 5.21 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.33 -0.856 . . . . 0.0 110.202 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.4 Cg_endo -86.74 -40.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.933 1.491 . . . . 0.0 110.469 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 5' ' ' ILE . 13.3 mt -51.55 -31.9 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.243 -0.911 . . . . 0.0 110.032 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -94.14 -26.35 16.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 110.052 179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -80.19 -6.56 58.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 110.26 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -170.87 40.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.9 . . . . 0.0 110.292 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 9' ' ' ILE . 4.7 t80 -178.45 38.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 110.224 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.335 0 O-C-N 119.817 -1.802 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.422 ' O ' ' C ' ' A' ' 2' ' ' LEU . 1.5 tp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.182 0.515 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 1' ' ' ILE . 0.2 OUTLIER -42.68 -89.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.892 . . . . 0.0 110.23 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.406 ' O ' ' HD2' ' A' ' 7' ' ' LYS . . . 166.73 74.88 0.03 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -81.3 1.52 32.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.363 -1.081 . . . . 0.0 110.146 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.635 ' O ' HD13 ' A' ' 9' ' ' ILE . 14.1 pt -124.74 -11.71 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 110.167 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -103.27 -32.83 9.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 110.039 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.543 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 29.9 mttp -60.91 -54.25 56.16 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 0.0 110.246 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 46.8 Cg_endo -67.44 -31.03 35.27 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.896 1.472 . . . . 0.0 110.308 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 5' ' ' ILE . 1.1 mp -59.56 -26.05 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.656 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.43 -21.67 38.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.817 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -49.91 63.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 110.097 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 12' ' ' LEU . 2.7 mt -74.55 -10.49 59.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.177 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -118.28 29.77 7.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 110.185 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.343 0 O-C-N 119.845 -1.785 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 2' ' ' LEU . 1.5 tt . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.205 0.526 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 1' ' ' ILE . 2.5 mt 56.58 164.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.208 -0.933 . . . . 0.0 110.124 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.19 37.07 0.03 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.9 ttmm -50.12 -20.97 1.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -1.095 . . . . 0.0 110.356 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.524 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 1.9 tt -144.41 13.16 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 110.2 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.631 ' CZ3' HG21 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -105.72 -40.06 5.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 110.112 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.544 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 3.5 ttmt -51.71 -54.4 40.3 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.342 -0.849 . . . . 0.0 110.296 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.0 Cg_endo -67.59 -43.75 5.25 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.923 1.486 . . . . 0.0 110.196 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.631 HG21 ' CZ3' ' A' ' 6' ' ' TRP . 5.7 mm -49.97 -25.87 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.171 -0.956 . . . . 0.0 109.968 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -92.99 -24.2 18.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.888 . . . . 0.0 110.098 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.29 -17.38 64.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.361 -0.837 . . . . 0.0 110.266 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -126.96 15.99 7.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.873 . . . . 0.0 110.117 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 2.5 t80 -140.39 -48.86 0.44 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 110.241 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.331 0 O-C-N 119.865 -1.772 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 1' ' ' ILE . 4.8 mp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.216 0.531 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 1' ' ' ILE . 35.2 mt -144.97 -37.27 0.29 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 110.331 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.75 90.69 0.08 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -76.8 -7.84 56.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -1.136 . . . . 0.0 110.1 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.503 ' O ' HD13 ' A' ' 9' ' ' ILE . 9.7 tp -142.62 13.83 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.055 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -122.74 -27.07 4.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 110.06 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.52 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 17.0 mttt -64.52 -42.8 68.25 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.314 -0.867 . . . . 0.0 110.245 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.6 Cg_endo -84.09 -37.61 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.985 1.518 . . . . 0.0 110.441 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.519 ' N ' HD12 ' A' ' 9' ' ' ILE . 1.5 mp -50.43 -46.39 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 0.0 109.904 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.444 ' C ' ' CD ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -66.15 -17.93 65.03 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.998 179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -82.36 -62.77 1.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 110.121 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 12' ' ' LEU . 33.5 mt -53.52 -22.04 7.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.184 -0.948 . . . . 0.0 110.037 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -135.88 56.48 1.82 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 110.186 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.323 0 O-C-N 119.872 -1.767 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 2' ' ' LEU . 3.4 mt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.293 0.568 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 1' ' ' ILE . 6.1 mt 60.54 -84.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -0.946 . . . . 0.0 110.281 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.441 ' HA3' ' HB2' ' A' ' 6' ' ' TRP . . . -106.44 66.29 0.26 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -46.42 -23.96 0.44 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -1.059 . . . . 0.0 110.265 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.464 ' O ' ' CG1' ' A' ' 9' ' ' ILE . 5.1 tp -103.81 -1.93 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 110.216 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.444 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 6.5 m95 -97.46 -33.1 11.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.174 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.545 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -55.59 -36.14 42.33 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 110.036 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 48.2 Cg_endo -92.28 -37.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.985 1.519 . . . . 0.0 110.14 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.464 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 8.1 mt -68.79 -26.11 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.989 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.481 ' O ' ' CD ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -73.32 -29.25 62.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.879 . . . . 0.0 110.102 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -91.84 -39.54 11.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.322 -0.861 . . . . 0.0 110.09 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -56.34 -25.23 48.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.312 -0.868 . . . . 0.0 110.201 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -55.8 87.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.258 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . 0.439 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.341 0 O-C-N 119.829 -1.794 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.642 HD12 ' N ' ' A' ' 1' ' ' ILE . 2.3 mp . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.199 0.523 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.449 ' H ' HD12 ' A' ' 2' ' ' LEU . 3.3 mp -42.4 -90.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 110.164 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.525 ' O ' ' CD ' ' A' ' 8' ' ' PRO . . . -162.52 91.19 0.11 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.491 ' C ' ' CG1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -79.96 47.69 0.9 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -1.173 . . . . 0.0 109.851 179.419 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.491 ' CG1' ' C ' ' A' ' 4' ' ' LYS . 12.3 mt -152.65 -36.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.313 -0.867 . . . . 0.0 110.292 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.471 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 6.0 t-105 -145.1 -36.57 0.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.063 -1.023 . . . . 0.0 110.857 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.571 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -42.59 -27.43 0.27 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.92 . . . . 0.0 110.423 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.571 ' HD3' ' CB ' ' A' ' 7' ' ' LYS . 48.7 Cg_endo -115.64 -56.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.771 1.406 . . . . 0.0 110.434 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.463 HD12 ' C ' ' A' ' 5' ' ' ILE . 6.6 mt -44.33 -26.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.339 -0.85 . . . . 0.0 110.294 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.488 ' CD ' ' C ' ' A' ' 10' ' ' LYS . 2.9 tmtt? -61.39 -38.36 86.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.892 . . . . 0.0 110.293 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -76.41 -45.76 30.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 110.374 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.1 mt -77.87 -21.84 50.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 110.375 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -112.36 63.91 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.193 -0.942 . . . . 0.0 110.255 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.355 0 O-C-N 119.845 -1.784 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.456 ' O ' ' N ' ' A' ' 3' ' ' GLY . 3.7 tt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.195 0.522 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 1' ' ' ILE . 0.3 OUTLIER 58.8 -85.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.197 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 1' ' ' ILE . . . 160.5 104.78 0.2 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -83.4 10.12 9.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -1.152 . . . . 0.0 110.176 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.65 ' O ' HD12 ' A' ' 9' ' ' ILE . 12.4 mt -123.96 -16.99 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.307 -0.871 . . . . 0.0 110.259 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -101.36 -24.28 14.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.15 -0.969 . . . . 0.0 109.896 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -78.91 -31.99 0.76 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.848 . . . . 0.0 110.298 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 47.4 Cg_endo -91.1 -34.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.795 1.418 . . . . 0.0 110.407 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.65 HD12 ' O ' ' A' ' 5' ' ' ILE . 5.5 mt -57.23 -57.6 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 109.703 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -56.6 -26.47 55.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.942 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -48.17 55.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 110.147 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.7 mt -91.14 11.63 22.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 1.4 t80 -81.58 -40.85 22.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.223 -0.923 . . . . 0.0 110.238 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.352 0 O-C-N 119.826 -1.797 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.66 ' N ' HD12 ' A' ' 1' ' ' ILE . 2.4 mp . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.249 0.547 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.404 ' HB3' ' HE3' ' A' ' 7' ' ' LYS . 2.4 mt 50.42 -89.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.237 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 1' ' ' ILE . . . -122.13 71.8 0.39 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.8 -12.56 17.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -1.105 . . . . 0.0 110.082 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.869 ' O ' HD12 ' A' ' 9' ' ' ILE . 13.1 tt -143.96 40.09 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.001 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 26.6 t-105 -148.12 -37.83 0.19 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.875 . . . . 0.0 110.205 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -63.0 -48.82 83.95 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.345 -0.847 . . . . 0.0 110.253 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 47.4 Cg_endo -76.14 -36.62 1.82 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.995 1.524 . . . . 0.0 110.379 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.869 HD12 ' O ' ' A' ' 5' ' ' ILE . 27.5 mt -65.93 -19.58 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.9 . . . . 0.0 110.062 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -85.51 -30.74 23.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 110.046 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -59.37 2.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.69 -60.7 3.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 0.0 110.227 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 6.1 m-30 -79.84 -150.7 0.06 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 110.284 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.345 0 O-C-N 119.825 -1.797 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.415 ' C ' ' HG ' ' A' ' 2' ' ' LEU . 52.2 mt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.29 0.567 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.415 ' HG ' ' C ' ' A' ' 1' ' ' ILE . 3.6 mt -127.82 126.53 41.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.184 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 6' ' ' TRP . . . 84.27 89.6 0.8 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 4' ' ' LYS . 11.2 ttmt -60.33 -13.73 14.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.331 -1.099 . . . . 0.0 110.118 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.643 ' O ' HD12 ' A' ' 9' ' ' ILE . 10.8 mt -135.16 2.47 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.192 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.496 ' HB2' ' HA3' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -90.43 -29.56 17.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 110.184 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.557 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.0 mtmm -67.78 -37.18 11.25 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 110.356 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 7' ' ' LYS . 48.5 Cg_endo -84.3 -44.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.654 1.344 . . . . 0.0 110.193 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.643 HD12 ' O ' ' A' ' 5' ' ' ILE . 24.7 mt -51.09 -21.82 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.148 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.476 ' HD3' ' O ' ' A' ' 10' ' ' LYS . 5.1 tmtt? -77.47 -34.16 54.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 110.232 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -85.17 -53.38 5.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.879 . . . . 0.0 110.22 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.96 -38.91 58.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.229 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 13.7 m-85 -106.62 168.72 8.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.375 -0.828 . . . . 0.0 110.182 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.32 0 O-C-N 119.867 -1.77 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 42.9 mt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.251 0.548 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 mt 51.9 -164.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.223 -0.923 . . . . 0.0 110.258 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 112.1 82.71 1.24 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.46 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -85.01 -17.22 38.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -1.099 . . . . 0.0 110.151 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.651 ' O ' HD12 ' A' ' 9' ' ' ILE . 21.5 mm -125.73 -7.17 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 109.99 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.95 -27.83 13.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 110.01 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.567 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 5.1 tttt -74.77 -34.48 1.79 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 110.356 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 48.5 Cg_endo -87.04 -36.94 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.726 1.382 . . . . 0.0 110.346 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.651 HD12 ' O ' ' A' ' 5' ' ' ILE . 6.1 mt -57.67 -37.08 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 109.876 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -20.86 62.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.98 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -68.94 -54.82 13.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.3 -0.875 . . . . 0.0 110.195 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 12' ' ' LEU . 19.4 mt -89.27 28.6 1.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 110.214 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -106.26 -153.68 0.5 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.902 . . . . 0.0 110.179 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.358 0 O-C-N 119.89 -1.756 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 2' ' ' LEU . 20.1 pt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.233 0.54 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 1' ' ' ILE . 1.5 mt -55.83 -163.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 110.185 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' A' ' 6' ' ' TRP . . . -78.39 0.06 76.59 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.45 -24.37 0.5 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -1.207 . . . . 0.0 109.924 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.425 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 24.1 mt -124.31 3.91 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 110.218 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.532 ' CE2' ' HB3' ' A' ' 10' ' ' LYS . 20.4 t-105 -87.54 -25.45 23.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 110.265 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.538 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -52.07 -33.03 9.97 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 110.285 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 47.7 Cg_endo -99.24 -55.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.041 1.548 . . . . 0.0 110.417 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 14.2 mm -48.55 -56.23 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.284 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.532 ' HB3' ' CE2' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -67.47 -34.1 76.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.042 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.486 ' N ' ' HG3' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -41.63 -59.03 1.75 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.577 -0.702 . . . . 0.0 110.342 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.483 ' HA ' HD23 ' A' ' 12' ' ' LEU . 11.1 mt -76.13 -13.83 60.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 110.275 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.27 -83.29 0.61 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.216 -0.928 . . . . 0.0 110.206 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . 0.418 ' N ' ' O ' ' A' ' 10' ' ' LYS . . . . . . . . 0 C--N 1.306 -1.326 0 O-C-N 119.876 -1.765 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.475 ' HA ' HD13 ' A' ' 1' ' ' ILE . 13.1 mm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.257 0.551 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.87 160.75 14.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.197 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.79 70.09 0.24 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.44 ' NZ ' HD11 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -45.51 -34.49 3.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.461 -1.023 . . . . 0.0 110.558 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.83 ' O ' HD13 ' A' ' 9' ' ' ILE . 4.4 mt -128.49 26.21 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 110.36 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.56 ' HA ' ' CE3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -145.75 -35.99 0.29 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 0.0 110.63 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.522 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -57.62 -38.64 69.56 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 110.093 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 7' ' ' LYS . 46.7 Cg_endo -89.78 -49.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.867 1.456 . . . . 0.0 110.058 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.83 HD13 ' O ' ' A' ' 5' ' ' ILE . 1.3 mp -52.43 -20.32 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.837 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.403 ' CD ' ' C ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -66.71 -30.87 71.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 109.969 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -82.21 -31.87 30.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.305 -0.872 . . . . 0.0 110.076 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.16 -25.64 67.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.15 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.13 161.79 10.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -0.857 . . . . 0.0 110.206 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.367 0 O-C-N 119.855 -1.778 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.741 HD12 ' C ' ' A' ' 1' ' ' ILE . 2.6 pp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.221 0.534 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 46.4 mt -108.82 -169.86 1.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 110.134 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 49.44 77.89 0.11 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -73.46 -0.62 15.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.347 -1.09 . . . . 0.0 110.388 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.711 ' O ' HG22 ' A' ' 5' ' ' ILE . 60.1 mt -145.81 20.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 110.012 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -129.08 -26.77 2.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.313 -0.867 . . . . 0.0 110.443 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 9.6 tttp -80.72 -28.15 0.48 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 110.629 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 7' ' ' LYS . 47.7 Cg_endo -101.12 -27.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.756 1.398 . . . . 0.0 110.672 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.525 HD13 ' HA ' ' A' ' 9' ' ' ILE . 3.5 mm -53.09 -68.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.128 -0.983 . . . . 0.0 110.082 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.469 ' N ' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -63.3 -23.63 67.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 110.407 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 7' ' ' LYS . 1.8 tttt -71.14 -57.2 4.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.44 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.47 -24.3 59.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.167 -0.958 . . . . 0.0 110.459 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.0 106.88 19.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.141 -0.974 . . . . 0.0 110.32 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 119.94 -1.725 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 6.4 mt . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.206 0.527 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.412 ' H ' HD23 ' A' ' 2' ' ' LEU . 0.5 OUTLIER -82.99 -160.63 0.42 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 110.276 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 156.72 77.02 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -76.67 -11.08 59.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.366 -1.079 . . . . 0.0 110.41 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.788 ' C ' HD13 ' A' ' 9' ' ' ILE . 9.8 tt -142.84 24.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 0.0 110.243 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.422 ' HA ' ' HB ' ' A' ' 9' ' ' ILE . 46.4 t-105 -137.98 -36.78 0.6 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.89 . . . . 0.0 110.167 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.52 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -48.96 -45.64 74.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 110.092 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.681 ' HG2' HD12 ' A' ' 9' ' ' ILE . 46.6 Cg_endo -91.64 -46.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.073 1.565 . . . . 0.0 110.406 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.788 HD13 ' C ' ' A' ' 5' ' ' ILE . 2.1 mp -50.83 -43.37 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.247 -0.908 . . . . 0.0 109.94 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.496 ' C ' ' CD ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -60.1 -18.84 50.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.916 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -26.0 25.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.865 . . . . 0.0 110.161 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -76.2 -22.28 55.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 110.25 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -58.47 -177.18 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.161 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.367 0 O-C-N 119.877 -1.765 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_